<SEC-DOCUMENT>0001062993-25-014806.txt : 20250822
<SEC-HEADER>0001062993-25-014806.hdr.sgml : 20250822
<ACCEPTANCE-DATETIME>20250822163111
ACCESSION NUMBER:		0001062993-25-014806
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20250821
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250822
DATE AS OF CHANGE:		20250822

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Medicus Pharma Ltd.
		CENTRAL INDEX KEY:			0001997296
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				981778211
		STATE OF INCORPORATION:			A6
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-42408
		FILM NUMBER:		251246696

	BUSINESS ADDRESS:	
		STREET 1:		300 CONSHOHOCKEN STATE RD.
		STREET 2:		SUITE 200
		CITY:			W. CONSHOHOCKEN
		STATE:			PA
		ZIP:			19428
		BUSINESS PHONE:		610-540-7515

	MAIL ADDRESS:	
		STREET 1:		300 CONSHOHOCKEN STATE RD.
		STREET 2:		SUITE 200
		CITY:			W. CONSHOHOCKEN
		STATE:			PA
		ZIP:			19428
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:mdcx="http://www.medicuspharma.com/20250821" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:currency="http://xbrl.sec.gov/currency/2025" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:stpr="http://xbrl.sec.gov/stpr/2025" xmlns:exch="http://xbrl.sec.gov/exch/2025" xmlns:naics="http://xbrl.sec.gov/naics/2025" xmlns:sic="http://xbrl.sec.gov/sic/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">

<head>
    <title>Medicus Pharma Ltd.: Form 8-K - Filed by newsfilecorp.com</title>
</head>

<body style="font-size:10pt;font-family:Times New Roman;">

    <div style="font-family: Times New Roman; font-size: 10pt; line-height: initial;">
        <hr style="width: 100%; color: #000000; height: 3px; background-color: black;"/><a id="page_1"></a>
        <div style="display: none;">
            <ix:header>
                <ix:hidden>
                    <ix:nonNumeric name="dei:AmendmentFlag" contextRef="CR20250821" id="ixv-253">false</ix:nonNumeric>
                    <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="CR20250821" id="ixv-254">2025-08-21</ix:nonNumeric>
                    <ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="CR20250821" id="ixv-255">0001997296</ix:nonNumeric>
                    <ix:nonNumeric name="dei:EntityRegistrantName" id="EntityRegistrantName" contextRef="CR20250821">Medicus Pharma Ltd.</ix:nonNumeric>
                </ix:hidden>
                <ix:references>
                    <link:schemaRef xlink:href="mdcx-20250821.xsd" xlink:type="simple"/>
                </ix:references>
                <ix:resources>
                    <xbrli:context id="CR20250821">
                        <xbrli:entity>
                            <xbrli:identifier scheme="http://www.sec.gov/CIK">0001997296</xbrli:identifier>
                        </xbrli:entity>
                        <xbrli:period>
                            <xbrli:startDate>2025-08-21</xbrli:startDate>
                            <xbrli:endDate>2025-08-21</xbrli:endDate>
                        </xbrli:period>
                    </xbrli:context>
                    <xbrli:context id="CR20250821_dei_EntityListingsExchangeAxis_exch_XNCM_us-gaap_StatementClassOfStockAxis_mdcx_CommonSharesNoParValueMember">
                        <xbrli:entity>
                            <xbrli:identifier scheme="http://www.sec.gov/CIK">0001997296</xbrli:identifier>
                            <xbrli:segment>
                                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNCM</xbrldi:explicitMember>
                                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdcx:CommonSharesNoParValueMember</xbrldi:explicitMember>
                            </xbrli:segment>
                        </xbrli:entity>
                        <xbrli:period>
                            <xbrli:startDate>2025-08-21</xbrli:startDate>
                            <xbrli:endDate>2025-08-21</xbrli:endDate>
                        </xbrli:period>
                    </xbrli:context>
                    <xbrli:context id="CR20250821_dei_EntityListingsExchangeAxis_exch_XNCM_us-gaap_StatementClassOfStockAxis_mdcx_WarrantsEachExercisableForOneCommonShareAtAnExercisePriceOfFourPointSixFourPerShareMember">
                        <xbrli:entity>
                            <xbrli:identifier scheme="http://www.sec.gov/CIK">0001997296</xbrli:identifier>
                            <xbrli:segment>
                                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNCM</xbrldi:explicitMember>
                                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdcx:WarrantsEachExercisableForOneCommonShareAtAnExercisePriceOfFourPointSixFourPerShareMember</xbrldi:explicitMember>
                            </xbrli:segment>
                        </xbrli:entity>
                        <xbrli:period>
                            <xbrli:startDate>2025-08-21</xbrli:startDate>
                            <xbrli:endDate>2025-08-21</xbrli:endDate>
                        </xbrli:period>
                    </xbrli:context>
                </ix:resources>
            </ix:header>
        </div>
        <p style="text-align: center; margin-top: 10pt; margin-bottom: 10pt;"><b><span style="font-size: 25pt;">UNITED STATES</span></b><br/><b><span style="font-size: 25pt;">SECURITIES AND EXCHANGE COMMISSION</span></b><br/>Washington, D.C. 20549<br/><b>___________________________</b></p>
        <p style="text-align: center; margin-top: 10pt; margin-bottom: 10pt;"><b><span style="font-size: 25pt;">FORM <ix:nonNumeric name="dei:DocumentType" contextRef="CR20250821" id="ixv-284">8-K</ix:nonNumeric></span></b></p>
        <p style="text-align: center; margin-top: 10pt; margin-bottom: 10pt;"><b>CURRENT REPORT</b><br/><b>Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</b></p>
        <p style="text-align: center; margin-top: 10pt; margin-bottom: 10pt;">Date of Report (Date of earliest event reported): <span style="text-decoration: underline; font-weight: bold;">
                <ix:nonNumeric name="dei:DocumentCreationDate" format="ixt:datemonthdayyearen" contextRef="CR20250821" id="ixv-285">August 21, 2025</ix:nonNumeric>
            </span></p>
        <p style="text-align: center; margin-top: 10pt; margin-bottom: 10pt;"><span style="text-decoration: underline; font-weight: bold; font-size: 25pt; -sec-ix-hidden: EntityRegistrantName;">MEDICUS PHARMA LTD.</span><br/>(Exact name of registrant as specified in its charter)</p>
        <table style="border-color: black; font-size: 10pt; border-collapse: collapse; width: 100%;">
            <tr style="vertical-align: top;">
                <td style="text-align: center;"><span style="text-decoration: underline; font-weight: bold;">
                        <ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:edgarprovcountryen" contextRef="CR20250821" id="ixv-286">Ontario</ix:nonNumeric>
                    </span></td>
                <td style="text-align: center; width: 33%;"><span style="text-decoration: underline; font-weight: bold;">
                        <ix:nonNumeric name="dei:EntityFileNumber" contextRef="CR20250821" id="ixv-287">001-42408</ix:nonNumeric>
                    </span></td>
                <td style="text-align: center; width: 33%;"><span style="text-decoration: underline; font-weight: bold;">
                        <ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="CR20250821" id="ixv-288">98-1778211</ix:nonNumeric>
                    </span></td>
            </tr>
            <tr style="vertical-align: top;">
                <td style="text-align: center;">(State or other jurisdiction</td>
                <td style="text-align: center; width: 33%;">(Commission</td>
                <td style="text-align: center; width: 33%;">(IRS Employer</td>
            </tr>
            <tr style="vertical-align: top;">
                <td style="text-align: center;">of incorporation)</td>
                <td style="text-align: center; width: 33%;">File Number)</td>
                <td style="text-align: center; width: 33%;">Identification No.)</td>
            </tr>
        </table>
        <p style="text-align: center; margin-top: 10pt; margin-bottom: 10pt;"><span style="font-weight: bold;">
                <ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="CR20250821" id="ixv-289">300 Conshohocken State Road, Suite 200</ix:nonNumeric><br/>
            </span> <span style="text-decoration: underline; font-weight: bold;">
                <ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="CR20250821" id="ixv-290">Conshohocken</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" contextRef="CR20250821" id="ixv-291">Pennsylvania</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCountry" format="ixt-sec:countrynameen" contextRef="CR20250821" id="ixv-292">United States</ix:nonNumeric>
                <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="CR20250821" id="ixv-293">19428</ix:nonNumeric><br/>
            </span> (Address of principal executive offices) (ZIP Code)</p>
        <p style="text-align: center; margin-top: 10pt; margin-bottom: 10pt;">Registrant&#8217;s telephone number, including area code: <span style="text-decoration: underline; font-weight: bold;">(<ix:nonNumeric name="dei:CityAreaCode" contextRef="CR20250821" id="ixv-294">610</ix:nonNumeric>) <ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="CR20250821" id="ixv-295">540-7515</ix:nonNumeric></span></p>
        <p style="text-align: justify; margin-top: 10pt; margin-bottom: 10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>
        <p style="text-align: justify; margin-top: 10pt; margin-bottom: 10pt;">
            <ix:nonNumeric name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" contextRef="CR20250821" id="ixv-296">&#9744;</ix:nonNumeric> Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
        </p>
        <p style="text-align: justify; margin-top: 10pt; margin-bottom: 10pt;">
            <ix:nonNumeric name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" contextRef="CR20250821" id="ixv-297">&#9744;</ix:nonNumeric> Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
        </p>
        <p style="text-align: justify; margin-top: 10pt; margin-bottom: 10pt;">
            <ix:nonNumeric name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" contextRef="CR20250821" id="ixv-298">&#9744;</ix:nonNumeric> Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
        </p>
        <p style="text-align: justify; margin-top: 10pt; margin-bottom: 10pt;">
            <ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" contextRef="CR20250821" id="ixv-299">&#9744;</ix:nonNumeric> Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
        </p>
        <p style="margin-top: 10pt; margin-bottom: 10pt;">Securities registered pursuant to Section 12(b) of the Act:</p>
        <table style="border-color: black; font-size: 10pt; border-collapse: collapse; width: 100%;">
            <tr style="vertical-align: top;">
                <td style="text-align: center; border-bottom: 1px solid;"><b>Title of each class</b></td>
                <td style="width: 5%;">&#160;</td>
                <td style="text-align: center; width: 30%; border-bottom: 1px solid;"><b>Trading Symbols</b></td>
                <td style="width: 5%;">&#160;</td>
                <td style="text-align: center; width: 30%; border-bottom: 1px solid;"><b>Name of each exchange on which registered</b></td>
            </tr>
            <tr style="vertical-align: top;">
                <td style="text-align: center;">
                    <ix:nonNumeric name="dei:Security12bTitle" contextRef="CR20250821_dei_EntityListingsExchangeAxis_exch_XNCM_us-gaap_StatementClassOfStockAxis_mdcx_CommonSharesNoParValueMember" id="ixv-300">Common shares, no par value</ix:nonNumeric>
                </td>
                <td style="width: 5%;">&#160;</td>
                <td style="text-align: center; width: 30%;">
                    <ix:nonNumeric name="dei:TradingSymbol" contextRef="CR20250821_dei_EntityListingsExchangeAxis_exch_XNCM_us-gaap_StatementClassOfStockAxis_mdcx_CommonSharesNoParValueMember" id="ixv-301">MDCX</ix:nonNumeric>
                </td>
                <td style="width: 5%;">&#160;</td>
                <td style="text-align: center; width: 30%;">
                    <ix:nonNumeric name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" contextRef="CR20250821_dei_EntityListingsExchangeAxis_exch_XNCM_us-gaap_StatementClassOfStockAxis_mdcx_CommonSharesNoParValueMember" id="ixv-302">NASDAQ</ix:nonNumeric> Capital Market
                </td>
            </tr>
            <tr style="vertical-align: top;">
                <td style="text-align: center;">
                    <ix:nonNumeric name="dei:Security12bTitle" contextRef="CR20250821_dei_EntityListingsExchangeAxis_exch_XNCM_us-gaap_StatementClassOfStockAxis_mdcx_WarrantsEachExercisableForOneCommonShareAtAnExercisePriceOfFourPointSixFourPerShareMember" id="ixv-303">Warrants, each exercisable for one common share at an exercise price of $4.64 per share</ix:nonNumeric>
                </td>
                <td style="width: 5%;">&#160;</td>
                <td style="text-align: center; width: 30%;">
                    <ix:nonNumeric name="dei:TradingSymbol" contextRef="CR20250821_dei_EntityListingsExchangeAxis_exch_XNCM_us-gaap_StatementClassOfStockAxis_mdcx_WarrantsEachExercisableForOneCommonShareAtAnExercisePriceOfFourPointSixFourPerShareMember" id="ixv-304">MDCXW</ix:nonNumeric>
                </td>
                <td style="width: 5%;">&#160;</td>
                <td style="text-align: center; width: 30%;">
                    <ix:nonNumeric name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" contextRef="CR20250821_dei_EntityListingsExchangeAxis_exch_XNCM_us-gaap_StatementClassOfStockAxis_mdcx_WarrantsEachExercisableForOneCommonShareAtAnExercisePriceOfFourPointSixFourPerShareMember" id="ixv-305">NASDAQ</ix:nonNumeric> Capital Market
                </td>
            </tr>
        </table>
        <p style="text-align: justify; margin-top: 10pt; margin-bottom: 10pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167; 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167; 240.12b -2 of this chapter).</p>
        <p style="text-align: justify; margin-top: 10pt; margin-bottom: 10pt;">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" contextRef="CR20250821" id="ixv-306">&#9745;</ix:nonNumeric>
        </p>
        <p style="text-align: justify; margin-top: 10pt; margin-bottom: 10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <ix:nonNumeric name="dei:EntityExTransitionPeriod" format="ixt-sec:boolballotbox" contextRef="CR20250821" id="ixv-307">&#9744;</ix:nonNumeric>
        </p>
        <hr style="page-break-after: always; width: 100%; color: #000000; height: 5px; background-color: black;"/><a id="page_2"></a>
        <p style="text-align: justify; margin-top: 10pt; margin-bottom: 10pt;"><b>Item 3.02. Unregistered Sales of Equity Securities.</b></p>
        <p style="text-indent: 36pt; text-align: justify; margin-top: 10pt; margin-bottom: 10pt;"><span style="background-color: #ffffff;">Pursuant to the previously disclosed Standby Equity Purchase Agreement (the "SEPA"), dated February 10, 2025, between Medicus Pharma Ltd. (the "Company") and YA II PN, Ltd. ("Yorkville"), the Company completed sales of its common shares (the "Common Shares") to Yorkville (collectively, the "SEPA Advances") as disclosed in the table below:</span></p>
        <table style="border-collapse: collapse; border: 0.75pt solid #000000; font-size: 10pt; width: 100%;" cellspacing="0" cellpadding="0">
            <tr>
                <td style="width: 25%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: middle; border-right: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: center; white-space: nowrap;"><span style="background-color: #ffffff;"><b>Date of Sale</b></span></td>
                <td style="border-left: 0.75pt solid #000000; width: 25%; vertical-align: middle; border-right: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; padding-right: 5.03pt; padding-left: 5.03pt; text-align: center; white-space: nowrap;"><span style="background-color: #ffffff;"><b>Number of Common<br/>Shares</b></span></td>
                <td style="border-left: 0.75pt solid #000000; width: 25%; vertical-align: middle; border-right: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; padding-right: 5.03pt; padding-left: 5.03pt; text-align: center; white-space: nowrap;"><span style="background-color: #ffffff;"><b>Price per share</b></span></td>
                <td style="width: 25%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: middle; border-bottom: 0.75pt solid #000000; border-left: 0.75pt solid #000000; text-align: center; white-space: nowrap;"><span style="background-color: #ffffff;"><b>Approximate Aggregate<br/>Consideration</b></span></td>
            </tr>
            <tr>
                <td style="width: 25%; vertical-align: middle; border-right: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; padding-right: 5.03pt; padding-left: 5.03pt; border-top: 0.75pt solid #000000; text-align: center;"><span style="background-color: #ffffff;">July 30, 2025</span></td>
                <td style="width: 25%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: middle; border: 0.75pt solid #000000; text-align: center;"><span style="background-color: #ffffff;">50,000</span></td>
                <td style="width: 25%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: middle; border: 0.75pt solid #000000; text-align: center;"><span style="background-color: #ffffff;">$2.8963</span></td>
                <td style="border-left: 0.75pt solid #000000; width: 25%; vertical-align: middle; border-bottom: 0.75pt solid #000000; padding-right: 5.03pt; padding-left: 5.03pt; border-top: 0.75pt solid #000000; text-align: center;"><span style="background-color: #ffffff;">$144,815</span></td>
            </tr>
            <tr>
                <td style="width: 25%; vertical-align: middle; border-right: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; padding-right: 5.03pt; padding-left: 5.03pt; border-top: 0.75pt solid #000000; text-align: center;"><span style="background-color: #ffffff;">August 12, 2025</span></td>
                <td style="width: 25%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: middle; border: 0.75pt solid #000000; text-align: center;"><span style="background-color: #ffffff;">200,000</span></td>
                <td style="width: 25%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: middle; border: 0.75pt solid #000000; text-align: center;"><span style="background-color: #ffffff;">$2.0425</span></td>
                <td style="border-left: 0.75pt solid #000000; width: 25%; vertical-align: middle; border-bottom: 0.75pt solid #000000; padding-right: 5.03pt; padding-left: 5.03pt; border-top: 0.75pt solid #000000; text-align: center;"><span style="background-color: #ffffff;">$408,500</span></td>
            </tr>
            <tr>
                <td style="width: 25%; vertical-align: middle; border-right: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; padding-right: 5.03pt; padding-left: 5.03pt; border-top: 0.75pt solid #000000; text-align: center;"><span style="background-color: #ffffff;">August 12, 2025</span></td>
                <td style="width: 25%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: middle; border: 0.75pt solid #000000; text-align: center;"><span style="background-color: #ffffff;">52,504</span></td>
                <td style="width: 25%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: middle; border: 0.75pt solid #000000; text-align: center;"><span style="background-color: #ffffff;">$1.94</span></td>
                <td style="border-left: 0.75pt solid #000000; width: 25%; vertical-align: middle; border-bottom: 0.75pt solid #000000; padding-right: 5.03pt; padding-left: 5.03pt; border-top: 0.75pt solid #000000; text-align: center;"><span style="background-color: #ffffff;">$101,858</span></td>
            </tr>
            <tr>
                <td style="width: 25%; vertical-align: middle; border-right: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; padding-right: 5.03pt; padding-left: 5.03pt; border-top: 0.75pt solid #000000; text-align: center;"><span style="background-color: #ffffff;">August 18, 2025</span></td>
                <td style="width: 25%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: middle; border: 0.75pt solid #000000; text-align: center;"><span style="background-color: #ffffff;">200,000</span></td>
                <td style="width: 25%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: middle; border: 0.75pt solid #000000; text-align: center;"><span style="background-color: #ffffff;">$1.9664</span></td>
                <td style="border-left: 0.75pt solid #000000; width: 25%; vertical-align: middle; border-bottom: 0.75pt solid #000000; padding-right: 5.03pt; padding-left: 5.03pt; border-top: 0.75pt solid #000000; text-align: center;"><span style="background-color: #ffffff;">$393,280</span></td>
            </tr>
            <tr>
                <td style="width: 25%; vertical-align: middle; border-right: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; padding-right: 5.03pt; padding-left: 5.03pt; border-top: 0.75pt solid #000000; text-align: center;"><span style="background-color: #ffffff;">August 18, 2025</span></td>
                <td style="width: 25%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: middle; border: 0.75pt solid #000000; text-align: center;"><span style="background-color: #ffffff;">7,150</span></td>
                <td style="width: 25%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: middle; border: 0.75pt solid #000000; text-align: center;"><span style="background-color: #ffffff;">$1.94</span></td>
                <td style="border-left: 0.75pt solid #000000; width: 25%; vertical-align: middle; border-bottom: 0.75pt solid #000000; padding-right: 5.03pt; padding-left: 5.03pt; border-top: 0.75pt solid #000000; text-align: center;"><span style="background-color: #ffffff;">$13,871</span></td>
            </tr>
            <tr>
                <td style="width: 25%; vertical-align: middle; border-right: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; padding-right: 5.03pt; padding-left: 5.03pt; border-top: 0.75pt solid #000000; text-align: center;"><span style="background-color: #ffffff;">August 21, 2025</span></td>
                <td style="width: 25%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: middle; border: 0.75pt solid #000000; text-align: center;"><span style="background-color: #ffffff;">300,000</span></td>
                <td style="width: 25%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: middle; border: 0.75pt solid #000000; text-align: center;"><span style="background-color: #ffffff;">$1.9638</span></td>
                <td style="border-left: 0.75pt solid #000000; width: 25%; vertical-align: middle; border-bottom: 0.75pt solid #000000; padding-right: 5.03pt; padding-left: 5.03pt; border-top: 0.75pt solid #000000; text-align: center;"><span style="background-color: #ffffff;">$589,140</span></td>
            </tr>
            <tr>
                <td style="width: 25%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: middle; border-top: 0.75pt solid #000000; border-right: 0.75pt solid #000000; text-align: center;"><span style="background-color: #ffffff;"><b>Total</b></span></td>
                <td style="width: 25%; vertical-align: middle; border-left: 0.75pt solid #000000; padding-right: 5.03pt; border-right: 0.75pt solid #000000; padding-left: 5.03pt; border-top: 0.75pt solid #000000; text-align: center;"><span style="text-decoration: underline;"><b> 809,654 </b></span></td>
                <td style="width: 25%; vertical-align: middle; border-left: 0.75pt solid #000000; padding-right: 5.03pt; border-right: 0.75pt solid #000000; padding-left: 5.03pt; border-top: 0.75pt solid #000000; text-align: center;">&#160;</td>
                <td style="width: 25%; padding-right: 5.03pt; padding-left: 5.03pt; vertical-align: middle; border-top: 0.75pt solid #000000; border-left: 0.75pt solid #000000; text-align: center;"><span style="background-color: #ffffff;"><span style="text-decoration: underline;"><b>$1,651,464</b></span></span></td>
            </tr>
        </table>
        <p style="text-indent: 36pt; text-align: justify; margin-top: 10pt; margin-bottom: 10pt;"><span style="background-color: #ffffff;">The Company may cause Yorkville to purchase additional Common Shares under the SEPA from time to time, subject to the satisfaction or waiver of the conditions and limitations set forth in the SEPA. The Company intends to use part of the net proceeds from the SEPA Advances to prepay a portion of the debentures the Company has outstanding with Yorkville, as described in that certain Current Report on Form 8-K dated June 20, 2025. The Common Shares were issued and sold to Yorkville in reliance upon the exemption from the registration requirements of the Securities Act of 1933, as amended (the "Securities Act"), afforded by Section 4(a)(2) of the Securities Act. The Company is relying on this exemption from registration based in part on representations made by Yorkville in the SEPA. Yorkville may resell the Common Shares it has purchased from the Company under the SEPA from time to time pursuant to that certain effective registration statement on form S-1 (File No. 333-287582), which has been filed by the Company in accordance with its requirements under the SEPA.</span></p>
        <p style="text-indent: 36pt; text-align: justify; margin-top: 10pt; margin-bottom: 10pt;"><span style="background-color: #ffffff;">In addition, on August 13, 2025, James Quinlan, the Chief Financial Officer of the Company, exercised stock options to purchase 125,000 Common Shares for cash at an exercise price of $0.81 per Common Share and stock options to purchase 20,000 Common Shares for cash at an exercise price of $2.75 per Common Share, for aggregate proceeds to the Company of approximately $156,250. The Common Shares were issued and sold to Mr. Quinlan in reliance upon the exemption from the registration requirements of the Securities Act afforded by Section 4(a)(2) of the Securities Act.</span></p>
        <p style="text-indent: 36pt; text-align: justify; margin-top: 10pt; margin-bottom: 10pt;"><span style="background-color: #ffffff;">This report shall not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction.</span></p>
        <p style="text-align: justify; margin-top: 10pt; margin-bottom: 10pt;"><b>Item 8.01. Other Events.</b></p>
        <p style="text-indent: 36pt; text-align: justify; margin-top: 10pt; margin-bottom: 10pt;">On August 21, 2025, the Company issued a press release relating to, among other things, updates regarding its proposed Type C Meeting with the United States Food and Drug Administration (the "FDA") and its second quarter 2025 financial highlights. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.</p>
        <hr style="break-after: page; text-align: center; height: 5px; color: #000000; background-color: #000000; width: 100%;"/><a id="page_3"></a>
        <p style="text-align: justify; margin-top: 10pt; margin-bottom: 10pt;"><b>Item 9.01. Financial Statements and Exhibits.</b></p>
        <p style="margin-bottom: 0pt; text-align: justify; margin-top: 10pt;">(d) Exhibits.</p>
        <p style="margin-top: 0pt; text-align: justify; margin-bottom: 10pt;"><span style="color: #ff0000;">&#8203;</span></p>
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" cellspacing="0" cellpadding="0">
            <tr>
                <td style="margin-top: 0pt; margin-bottom: 0pt; width: 8%; border-bottom: 0.75pt solid #000000; white-space: nowrap;"><b>Exhibit No.</b></td>
                <td style="margin-top: 0pt; margin-bottom: 0pt; width: 1%; white-space: nowrap;">&#160;</td>
                <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; white-space: nowrap;"><b>Description</b></td>
            </tr>
            <tr>
                <td style="margin-top: 0pt; margin-bottom: 0pt; width: 8%; background-color: #eeeeee;"><a href="exhibit99-1.htm">99.1</a></td>
                <td style="margin-top: 0pt; margin-bottom: 0pt; width: 1%; background-color: #eeeeee;"><span style="color: #ff0000;">&#160;</span></td>
                <td style="margin-top: 0pt; margin-bottom: 0pt; background-color: #eeeeee;"><a href="exhibit99-1.htm">Press Release, dated August 21, 2025</a></td>
            </tr>
            <tr>
                <td style="margin-top: 0pt; margin-bottom: 0pt; width: 8%;">104</td>
                <td style="margin-top: 0pt; margin-bottom: 0pt; width: 1%;"><span style="color: #ff0000;">&#8203;</span></td>
                <td style="margin-top: 0pt; margin-bottom: 0pt;">Cover Page Interactive Data File (embedded within the inline XBRL document).</td>
            </tr>
        </table>
        <p style="text-align: justify; margin-top: 10pt; margin-bottom: 10pt;"><b>Forward-Looking Statements</b></p>
        <p style="text-align: justify; margin-top: 10pt; margin-bottom: 10pt;"><i>Certain information in this news release constitutes "forward-looking information" under applicable securities laws. "Forward-looking information" is defined as disclosure regarding possible events, conditions or financial performance that is based on assumptions about future economic conditions and courses of action and includes, without limitation, statements regarding future sales of Common Shares under the SEPA to Yorkville and its proposed Type C Meeting with the FDA. Forward-looking statements are often but not always, identified by the use of such terms as "may", "on track", "aim", "might", "will", "will likely result", "would", "should", "estimate", "plan", "project", "forecast", "intend", "expect", "anticipate", "believe", "seek", "continue", "target" or the negative and/or inverse of such terms or other similar expressions. These statements involve known and unknown risks, uncertainties and other factors, which may cause actual results, performance or achievements to differ materially from those expressed or implied by such statements, including those risk factors described in the Company's public filings on EDGAR and on SEDAR+, which may impact, among other things, the trading price and liquidity of the Company's common shares. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement and reflect our expectations as of the date hereof and thus are subject to change thereafter. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.</i></p>
        <p style="text-align: justify; margin-top: 10pt; margin-bottom: 10pt;"><i>Readers are cautioned that the foregoing list is not exhaustive, and readers are encouraged to review the Company's long form prospectus accessible on the Company's profile on EDGAR at www.sec.gov and on SEDAR+ at www.sedarplus.ca. Readers are further cautioned not to place undue reliance on forward-looking statements as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated.</i></p>
        <hr style="break-after: page; text-align: center; height: 5px; color: #000000; background-color: #000000; width: 100%;"/><a id="page_4"></a>
        <p style="text-align: center; margin-top: 10pt; margin-bottom: 10pt;"><b>SIGNATURES</b></p>
        <p style="margin-bottom: 0pt; text-indent: 36pt; text-align: justify; margin-top: 10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.</p>
        <p style="margin-top: 0pt; text-align: justify; margin-bottom: 10pt;"><span style="color: #ff0000;">&#8203;</span></p>
        <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" cellspacing="0" cellpadding="0">
            <tr>
                <td style="margin-top: 0pt; margin-bottom: 0pt;">&#160;</td>
                <td style="margin-top: 0pt; margin-bottom: 0pt;" colspan="3"><b>MEDICUS PHARMA LTD.</b></td>
            </tr>
            <tr>
                <td style="margin-top: 0pt; margin-bottom: 0pt;">&#160;</td>
                <td style="margin-top: 0pt; margin-bottom: 0pt; width: 5%;">&#160;</td>
                <td style="margin-top: 0pt; margin-bottom: 0pt;" colspan="2">&#160;</td>
            </tr>
            <tr>
                <td style="margin-top: 0pt; margin-bottom: 0pt;">&#160;</td>
                <td style="margin-top: 0pt; margin-bottom: 0pt; width: 5%;">By:</td>
                <td style="margin-top: 0pt; margin-bottom: 0pt; width: 1%;">&#160;</td>
                <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000;">/s/ Raza Bokhari</td>
            </tr>
            <tr>
                <td style="margin-top: 0pt; margin-bottom: 0pt;">&#160;</td>
                <td style="margin-top: 0pt; margin-bottom: 0pt; width: 5%;">Name:</td>
                <td style="margin-top: 0pt; margin-bottom: 0pt; width: 1%;">&#160;</td>
                <td style="margin-top: 0pt; margin-bottom: 0pt;">Dr. Raza Bokhari</td>
            </tr>
            <tr>
                <td style="margin-top: 0pt; margin-bottom: 0pt;">&#160;</td>
                <td style="margin-top: 0pt; margin-bottom: 0pt; width: 5%;">Title:</td>
                <td style="margin-top: 0pt; margin-bottom: 0pt; width: 1%;">&#160;</td>
                <td style="margin-top: 0pt; margin-bottom: 0pt;">Executive Chairman and Chief Executive Officer</td>
            </tr>
        </table>
        <p style="margin-bottom: 0pt; text-align: justify; margin-top: 10pt;"><span style="color: #ff0000;">&#8203;</span></p>
        <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: justify;">Dated: August 22, 2025<span style="color: #ff0000;">&#8203;</span></p>
        <p style="margin-top: 0pt; text-align: justify; margin-bottom: 10pt;"><span style="color: #ff0000;">&#8203;</span></p>
        <hr style="height: 5px; color: #000000; background-color: #000000; width: 100%;"/>
    </div>

</body>

</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>

<head>
    <title>Medicus Pharma Ltd.: Exhibit 99.1 - Filed by newsfilecorp.com</title>
</head>

<body style="font-size:10pt; font-family:'Times New Roman';">
    <hr width="100%" size="3" color="black" noshade="noshade"><a name="page_1"></a>
    <p style="text-align: right; margin-top: 10pt; margin-bottom: 10pt;"><b>Exhibit 99.1</b></p>
    <p style="text-align: center; margin-top: 10pt; margin-bottom: 10pt;"><img src="exhibit99-1x001.jpg" style="width: 372px;" height="94"></p>
    <p style="margin-bottom: 0pt; text-align: center; margin-top: 10pt;"><font style="font-size: 12pt;"><b>MEDICUS PHARMA LTD. PROVIDES UPDATE ON DOXORUBICIN<br>CONTAINING NOVEL MICRONEEDLE ARRAY (D-MNA) CLINICAL<br>DEVELOPMENT PROGRAM FOR THE TREATMENT OF BASAL CELL<br>CARCINOMA (BCC) OF THE SKIN AND REPORTS SECOND QUARTER 2025<br>FINANCIAL HIGHLIGHTS</b></font></p>
    <p style="margin-bottom: 0pt; text-align: center; margin-top: 10pt;"><font style="font-size: 12pt;"><i>US Food and Drug Administration (FDA) has accepted the company's Type C meeting<br>request and SKNJCT-003 Phase 2 study has randomized more than 75% of patients</i></font></p>
    <p style="text-align: justify; margin-top: 10pt; margin-bottom: 10pt;">Philadelphia, PA - August 21, 2025 - Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advancing the clinical development programs of novel and potentially disruptive therapeutic assets,&#160; <font style="color: #1d2228;">is pleased to announce, following the acceptance of the Type C meeting request by the United States Food and Drug Administration (the "FDA"), the Company has submitted its queries in writing and expect to receive a response from the FDA before the end of Q3 2025.</font></p>
    <p style="text-align: justify; margin-top: 10pt; margin-bottom: 10pt;"><font style="color: #1d2228;">The purpose of the Type C meeting is to formally discuss the D-MNA product development and gain further alignment on the clinical pathway. The Company's aim is to gain the FDA's consent to fast-track the clinical development program and seek feedback on future clinical plans for the D-MNA development program.</font></p>
    <p style="text-align: justify; margin-top: 10pt; margin-bottom: 10pt;"><font style="color: #1d2228;">The Company also announced that its phase 2 clinical study to non-invasively treat BCC using novel D-MNA (SKNJCT-003) has now randomized more than seventy five percent (75%) of the ninety (90) participants expected to be randomized in the study. </font></p>
    <p style="text-align: justify; margin-top: 10pt; margin-bottom: 10pt;"><font style="color: #141414;"><b>Clinical Trial Design </b></font></p>
    <p style="text-align: justify; margin-top: 10pt; margin-bottom: 10pt;"><font style="color: #141414;">The clinical study (SKNJCT-003) is designed to be a randomized, double-blind, placebo-controlled (P-MNA), multi-center study originally enrolling up to sixty (60) subjects presenting with BCC of the skin. The study will evaluate the efficacy of two dose levels of D-MNA compared to a placebo control. The participants will be randomized 1:1:1 to one of three groups: a placebo-controlled group receiving P-MNA, a low-dose group receiving 100&#956;g of D-MNA, and a high-dose group receiving 200&#956;g of D-MNA.</font></p>
    <p style="text-align: justify; margin-top: 10pt; margin-bottom: 10pt;"><font style="color: #141414;">The high-dose, 200&#956;g D-MNA, proposed in the study is the maximum dose that was used in the Company's Phase 1 safety and tolerability study (SKNJCT-001) completed in March 2021.</font></p>
    <p style="text-align: justify; margin-top: 10pt; margin-bottom: 10pt;"><font style="color: #141414;">SKNJCT-001 met its primary objective of safety and tolerability. The investigational product, D-MNA, was well tolerated across all dose levels in all thirteen (13) participants enrolled in the study, with no dose-limiting toxicities (DLTs), or serious adverse events (SAEs). Furthermore, there were no systemic effects or clinically significant abnormal findings in laboratory parameters, vital signs, ECGs, and physical examinations. The study also describes the efficacy of the investigational product, D-MNA, with six (6) participants experiencing complete responses. The complete response is defined as the disappearance of BCC histologically in the final excision at the end of study visit. The participants profile demonstrating complete responses was diverse, and all participants (6/6) had nodular subtype of BCC.</font></p>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_2"></a>
    <p style="text-align: justify; margin-top: 10pt; margin-bottom: 10pt;"><font style="color: #1d2228;">SKNJCT-003 Phase 2 clinical study is currently underway in nine (9) clinical sites across the United States which commenced randomizing patients in August 2024.</font> In March 2025, the Company also announced a positively trending interim analysis for SKNJCT-003 demonstrating more than sixty percent (60%) clinical clearance. <font style="color: #1d2228;">The interim analysis was conducted after more than fifty percent (50%) of the then-targeted sixty (60) patients in the study were randomized. The findings of the interim analysis are preliminary and may or may not correlate with the findings of the study once completed. In April 2025, the investigational review board increased the number of participants in SKNJCT-003 to ninety (90) subjects. The Company also announced expanding clinical trial sites in Europe.</font></p>
    <p style="text-align: justify; margin-top: 10pt; margin-bottom: 10pt;"><font style="color: #1d2228;">The Company also has a clinical design (SKNJCT-004) currently underway in the United Arab Emirates (UAE). The study is expected to randomize thirty-six (36) patients in four (4) sites in the UAE. </font>Cleveland Clinic Abu Dhabi (<font style="color: #1d2228;">CCAD) is the principal investigator, along with </font>Sheikh Shakbout Medical City (SSMC)<font style="color: #1d2228;">, </font>Burjeel Medical City (BMC), and American Hospital of Dubai (AHD)<font style="color: #1d2228;">. Insights Research Organization and Solutions (IROS), a UAE-based contract research organization, is coordinating the clinical study for the Company. IROS is a M42 portfolio company.</font></p>
    <p style="text-align: justify; margin-top: 10pt; margin-bottom: 10pt;">In June 2025, the Company announced its entry into a definitive agreement to acquire Antev Ltd. ("Antev"), a UK-based clinical stage biotech company, developing <i>Teverelix<b>,</b></i> a next generation GnRH antagonist, as a first in market product for cardiovascular high-risk advanced prostate cancer patients and patients with first acute urinary retention relapse (AURr) episodes due to enlarged prostate.</p>
    <p style="text-align: justify; margin-top: 10pt; margin-bottom: 10pt;">In August 2025, the Company announced its entry into a non-binding memorandum of understanding (the "MoU") with Helix Nanotechnologies Inc. ("HelixNano"), a Boston-based biotech company focused on developing a proprietary advanced mRNA platform, in respect of their shared mutual interest in the development of thermostable infectious diseases mRNA vaccines. The MoU is non-binding and shall not be construed to obligate either party to proceed with the joint venture or any further development or commercial arrangement contemplated by the MoU, unless and until definitive agreements are executed.</p>
    <p style="text-align: justify; margin-top: 10pt; margin-bottom: 10pt;">In August 2025, certain insiders of the Company exercised 145,000 stock options at an exercise price of $0.84 and $2.87. These insiders exercised these stock options for tax and other personal financial planning purposes.</p>
    <p style="text-align: justify; margin-top: 10pt; margin-bottom: 10pt;">In August 2025, the Company also <font style="color: #1d2228;">announced its financial and operating results for the quarter ended June 30, 2025, highlights of which are provided below</font>.</p>
    <p style="text-align: justify; margin-top: 10pt; margin-bottom: 10pt;"><b>Second Quarter Financial Highlights</b></p>
    <p style="text-align: justify; margin-top: 10pt; margin-bottom: 10pt;">The addition of $11.5 million of aggregate net proceeds from financing transactions and the exercise of warrants has bolstered the Company's already strong balance sheet as it continues to progress its clinical development program while pursuing strategic transactions and building out its core management team.</p>
    <p style="text-align: justify; margin-top: 10pt; margin-bottom: 10pt;">Cash and cash equivalents were $9.7 million at the end of the second quarter compared to $4.0 million at the end of the first quarter.&#160;</p>
    <ul style="padding-left: 0pt;" type="disc">
        <li style="margin-left: 27.6pt; text-align: justify; padding-left: 8.4pt;">Total operating expenses were $6.0 million for the second quarter compared to $3.6 million for the same period in 2024. Research and development expenses were $1.4 million for the second quarter compared to $1.3 million for the same period in 2024.</li>
    </ul>
    <ul style="padding-left: 0pt;" type="disc">
        <li style="margin-left: 27.6pt; text-align: justify; padding-left: 8.4pt;">General and administrative expenses were $4.6 million for the second quarter compared to $2.3 million for the same period in 2024.</li>
    </ul>
    <ul style="padding-left: 0pt;" type="disc">
        <li style="margin-left: 27.6pt; text-align: justify; padding-left: 8.4pt;">Net loss for the second quarter was $6.2 million compared to $3.6 million for the same period in 2024. This reflects increased expenses as the Company accelerates its clinical development program, raises additional funding and pursues strategic growth.</li>
    </ul>
    <ul style="padding-left: 0pt;" type="disc">
        <li style="margin-left: 27.6pt; text-align: justify; padding-left: 8.4pt;"><font style="color: #1d2228;">The completion of a public offering of units for gross proceeds of $7.0 million.</font></li>
    </ul>
    <p style="text-align: justify; margin-top: 10pt; margin-bottom: 10pt;">The Company's complete financial statements for the quarter are included in its quarterly report on Form 10-Q, which was filed with the United States Securities and Exchange Commission on August 11, 2025, and are also available on SEDAR+.</p>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_3"></a>
    <p style="text-align: justify; margin-top: 10pt; margin-bottom: 10pt;"><font style="color: #1d2228;"><b>Management Commentary</b></font></p>
    <p style="text-align: justify; margin-top: 10pt; margin-bottom: 10pt;"><font style="color: #1d2228;">"The fundamentals of the Company are extremely strong today" stated Dr. Raza Bokhari, Executive Chairman and CEO "as we navigate through various opportunities available to us as a clinical stage company, we are making great progress with SkinJect while evaluating and selectively acting on other assets, as reflected by our agreement to acquire Antev and the possibility of a collaboration with HelixNano. Medicus' balance sheet is trending in a positive direction and management confidence level is high. Certain insiders have exercised stock options and expressed their intent to hold the shares, signaling their positive outlook for the prospects of the Company."</font></p>
    <p style="text-align: justify; margin-top: 10pt; margin-bottom: 10pt;"><b>For further information contact:</b></p>
    <p style="margin-bottom: 0pt; text-align: justify; margin-top: 10pt;">Carolyn Bonner, President</p>
    <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: justify;">(610) 636-0184</p>
    <p style="margin-top: 0pt; text-align: justify; margin-bottom: 10pt;">cbonner@medicuspharma.com&#160;</p>
    <p style="margin-bottom: 0pt; text-align: justify; margin-top: 10pt;">Anna Baran-Djokovic, SVP Investor Relations</p>
    <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: justify;">(305) 615-9162</p>
    <p style="margin-top: 0pt; text-align: justify; margin-bottom: 10pt;">adjokovic@medicuspharma.com&#160;</p>
    <p style="margin-left: 1pt; text-align: justify; margin-top: 10pt; margin-bottom: 10pt;"><i><b>About Medicus Pharma Ltd.</b></i></p>
    <p style="margin-left: 1pt; text-align: justify; margin-top: 10pt; margin-bottom: 10pt;"><i>Medicus Pharma Ltd. (Nasdaq: MDCX) is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutics assets. The Company is actively engaged in multiple countries, spread over three continents.</i></p>
    <p style="margin-left: 1pt; text-align: justify; margin-top: 10pt; margin-bottom: 10pt;"><i>SkinJect Inc. a wholly owned subsidiary of Medicus Pharma Ltd, is a development stage, life sciences company focused on commercializing novel, non-invasive treatment for basal cell skin cancer using patented dissolvable microneedle patch to deliver chemotherapeutic agent to eradicate tumors cells. The Company completed a phase 1 safety &amp; tolerability study (SKNJCT-001) in March of 2021, which met its primary objective of safety and tolerability; the study also describes the efficacy of the investigational product D-MNA, with six (6) participants experiencing complete response on histological examination of the resected lesion. The Company is currently conducting a randomized, controlled, double-blind, multicenter clinical study (SKNJCT-003) in the United States and Europe. The Company has also commenced a randomized, controlled, double-blind, multicenter clinical study (SKNJCT-004) in UAE.</i></p>
    <p style="margin-left: 1pt; text-align: justify; margin-top: 10pt; margin-bottom: 10pt;"><i>In June 2025, the Company announced its entry into a definitive agreement to acquire Antev, a UK-based late clinical stage biotech company, developing Teverelix, a next generation GnRH antagonist, as a first in market product for cardiovascular high-risk advanced prostate cancer patients and patients with first acute urinary retention relapse (AURr) episodes due to enlarged prostate. The transaction with Antev is subject to the fulfillment of certain closing conditions, including obtaining Antev shareholder approval and other applicable corporate, regulatory and third-party approvals. No assurances can be given that the parties will successfully close the proposed transaction on the terms or timeframe currently contemplated or at all<b>.</b></i></p>
    <hr style="page-break-after: always;" width="100%" size="5" color="black" noshade="noshade"><a name="page_4"></a>
    <p style="text-align: justify; margin-top: 10pt; margin-bottom: 10pt;"><i><b>Cautionary Notice on Forward-Looking Statements</b></i></p>
    <p style="text-align: justify; margin-top: 10pt; margin-bottom: 10pt;"><i>Certain information in this news release constitutes "forward-looking information" under applicable securities laws. "Forward-looking information" is defined as disclosure regarding possible events, conditions or financial performance that is based on assumptions about future economic conditions and courses of action and includes, without limitation, statements regarding the MOU, including the potential signing of definitive agreements between Medicus and HelixNano and the development of thermostable infectious diseases vaccines by combining HelixNano's proprietary mRNA vaccine platform with Medicus' proprietary microneedle array (MNA) delivery platform, the Company's aim to fast-track the clinical development program and convert the SKNJCT-003 exploratory clinical trial into a pivotal clinical trial, and approval from the FDA and the timing thereof, the Company's expectation of receiving a response from the FDA regarding its queries for its Type C Meeting before the end of Q3 2025, the commencement of the SKNJCT-004 study and the potential results of and benefits of such study, the Antev transaction, including the closing of the transaction or the timing thereof, the potential benefits of the Antev transaction, if consummated, including plans and expectations concerning, and future outcomes relating to, the development, advancement and commercialization of Teverelix, and the potential market opportunities related thereto. Forward-looking statements are often but not always, identified by the use of such terms as "may", "on track", "aim", "might", "will", "will likely result", "could," "designed," "would", "should", "estimate", "plan", "project", "forecast", "intend", "expect", "anticipate", "believe", "seek", "continue", "target" or the negative and/or inverse of such terms or other similar expressions. These statements involve known and unknown risks, uncertainties and other factors, which may cause actual results, performance or achievements to differ materially from those expressed or implied by such statements, including those risk factors described in the Company's public filings on EDGAR and on SEDAR+, which may impact, among other things, the trading price and liquidity of the Company's common shares. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement and reflect our expectations as of the date hereof and thus are subject to change thereafter. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. Readers are cautioned that the foregoing list is not exhaustive, and readers are encouraged to review the Company's long form prospectus accessible on the Company's profile on EDGAR at www.sec.gov and on SEDAR+ at www.sedarplus.ca . Readers are further cautioned not to place undue reliance on forward-looking statements as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. </i></p>
    <hr width="100%" size="5" color="black" noshade="noshade">
</body>

</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>mdcx-20250821.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<!-- Generated by Newsfile Corp. (www.newsfilecorp.com) -->
<xsd:schema attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.medicuspharma.com/20250821" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:mdcx="http://www.medicuspharma.com/20250821" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <xsd:import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
  <xsd:import namespace="http://fasb.org/us-roles/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd" />
  <xsd:import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/currency/2025" schemaLocation="https://xbrl.sec.gov/currency/2025/currency-2025.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/exch/2025" schemaLocation="https://xbrl.sec.gov/exch/2025/exch-2025.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/naics/2025" schemaLocation="https://xbrl.sec.gov/naics/2025/naics-2025.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/sic/2025" schemaLocation="https://xbrl.sec.gov/sic/2025/sic-2025.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/stpr/2025" schemaLocation="https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd" />
  <xsd:import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mdcx-20250821_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mdcx-20250821_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mdcx-20250821_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mdcx-20250821_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple" />
      <link:roleType id="DocumentAndEntityInformationDocument" roleURI="http://www.medicuspharma.com/role/DocumentAndEntityInformationDocument">
        <link:definition>0001000 - Document - Document and Entity Information Document</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <!-- Start custom elements -->
	<xsd:element id="mdcx_CommonSharesNoParValueMember" name="CommonSharesNoParValueMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
	<xsd:element id="mdcx_WarrantsEachExercisableForOneCommonShareAtAnExercisePriceOfFourPointSixFourPerShareMember" name="WarrantsEachExercisableForOneCommonShareAtAnExercisePriceOfFourPointSixFourPerShareMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />

  <!-- End custom elements -->
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>4
<FILENAME>mdcx-20250821_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<!-- Generated by Newsfile Corp. (www.newsfilecorp.com) -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<link:roleRef roleURI="http://www.medicuspharma.com/role/DocumentAndEntityInformationDocument" xlink:href="mdcx-20250821.xsd#DocumentAndEntityInformationDocument" xlink:type="simple" />
<link:calculationLink xlink:role="http://www.medicuspharma.com/role/DocumentAndEntityInformationDocument" xlink:type="extended" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>5
<FILENAME>mdcx-20250821_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<!-- Generated by Newsfile Corp. (www.newsfilecorp.com) -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.medicuspharma.com/role/DocumentAndEntityInformationDocument" xlink:href="mdcx-20250821.xsd#DocumentAndEntityInformationDocument" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple" />
  <link:definitionLink xlink:role="http://www.medicuspharma.com/role/DocumentAndEntityInformationDocument" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentInformationLineItems" xlink:label="loc_dei_DocumentInformationLineItems" xlink:type="locator" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentInformationTable" xlink:label="loc_dei_DocumentInformationTable" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="loc_dei_DocumentInformationTable" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />

	<!-- Address Axis -->

    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="loc_dei_EntityAddressesAddressTypeAxis" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_DocumentInformationTable" xlink:to="loc_dei_EntityAddressesAddressTypeAxis" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AddressTypeDomain" xlink:label="loc_dei_AddressTypeDomain_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_EntityAddressesAddressTypeAxis" xlink:to="loc_dei_AddressTypeDomain_default" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AddressTypeDomain" xlink:label="loc_dei_AddressTypeDomain" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_EntityAddressesAddressTypeAxis" xlink:to="loc_dei_AddressTypeDomain" xlink:type="arc" />
	<link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_FormerAddressMember" xlink:label="loc_dei_FormerAddressMember" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_AddressTypeDomain" xlink:to="loc_dei_FormerAddressMember" xlink:type="arc" />

	<!-- Exchange Axis -->

    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityListingsExchangeAxis" xlink:label="loc_dei_EntityListingsExchangeAxis" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_DocumentInformationTable" xlink:to="loc_dei_EntityListingsExchangeAxis" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_ExchangeDomain" xlink:label="loc_dei_ExchangeDomain_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_EntityListingsExchangeAxis" xlink:to="loc_dei_ExchangeDomain_default" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_ExchangeDomain" xlink:label="loc_dei_ExchangeDomain" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_EntityListingsExchangeAxis" xlink:to="loc_dei_ExchangeDomain" xlink:type="arc" />
	<link:loc xlink:href="https://xbrl.sec.gov/exch/2025/exch-2025.xsd#exch_XNYS" xlink:label="loc_exch_XNYS" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_ExchangeDomain" xlink:to="loc_exch_XNYS" xlink:type="arc" />
	<link:loc xlink:href="https://xbrl.sec.gov/exch/2025/exch-2025.xsd#exch_XNAS" xlink:label="loc_exch_XNAS" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_ExchangeDomain" xlink:to="loc_exch_XNAS" xlink:type="arc" />
	<link:loc xlink:href="https://xbrl.sec.gov/exch/2025/exch-2025.xsd#exch_XNGS" xlink:label="loc_exch_XNGS" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_ExchangeDomain" xlink:to="loc_exch_XNGS" xlink:type="arc" />
	<link:loc xlink:href="https://xbrl.sec.gov/exch/2025/exch-2025.xsd#exch_XTSX" xlink:label="loc_exch_XTSX" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_ExchangeDomain" xlink:to="loc_exch_XTSX" xlink:type="arc" />
	<link:loc xlink:href="https://xbrl.sec.gov/exch/2025/exch-2025.xsd#exch_XASE" xlink:label="loc_exch_XASE" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_ExchangeDomain" xlink:to="loc_exch_XASE" xlink:type="arc" />
	<link:loc xlink:href="https://xbrl.sec.gov/exch/2025/exch-2025.xsd#exch_XNMS" xlink:label="loc_exch_XNMS" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_ExchangeDomain" xlink:to="loc_exch_XNMS" xlink:type="arc" />
	<link:loc xlink:href="https://xbrl.sec.gov/exch/2025/exch-2025.xsd#exch_XNCM" xlink:label="loc_exch_XNCM" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_ExchangeDomain" xlink:to="loc_exch_XNCM" xlink:type="arc" />

	<!-- Class of Stock Axis -->

    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_DocumentInformationTable" xlink:to="loc_us-gaap_StatementClassOfStockAxis" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="loc_us-gaap_ClassOfStockDomain_default" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="loc_us-gaap_ClassOfStockDomain" xlink:type="arc" />
	<link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="loc_us-gaap_CommonStockMember" xlink:type="arc" />
	<link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaap_CommonClassAMember" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="loc_us-gaap_CommonClassAMember" xlink:type="arc" />
	<link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaap_CommonClassBMember" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="loc_us-gaap_CommonClassBMember" xlink:type="arc" />
	<link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaap_PreferredStockMember" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="loc_us-gaap_PreferredStockMember" xlink:type="arc" />
	<link:loc xlink:href="mdcx-20250821.xsd#mdcx_CommonSharesNoParValueMember" xlink:label="loc_mdcx_CommonSharesNoParValueMember" xlink:type="locator" />
	<link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="loc_mdcx_CommonSharesNoParValueMember" xlink:type="arc" />
	<link:loc xlink:href="mdcx-20250821.xsd#mdcx_WarrantsEachExercisableForOneCommonShareAtAnExercisePriceOfFourPointSixFourPerShareMember" xlink:label="loc_mdcx_WarrantsEachExercisableForOneCommonShareAtAnExercisePriceOfFourPointSixFourPerShareMember" xlink:type="locator" />
	<link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="loc_mdcx_WarrantsEachExercisableForOneCommonShareAtAnExercisePriceOfFourPointSixFourPerShareMember" xlink:type="arc" />


	<!-- Document info -->

    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="loc_dei_DocumentType" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentCreationDate" xlink:label="loc_dei_DocumentCreationDate" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="loc_dei_DocumentCreationDate" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="loc_dei_DocumentPeriodEndDate" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="loc_dei_DocumentFiscalYearFocus" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="loc_dei_AmendmentFlag" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="loc_dei_AmendmentDescription" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="loc_dei_AmendmentDescription" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_dei_NoTradingSymbolFlag" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="loc_dei_NoTradingSymbolFlag" xlink:type="arc" />

	<!-- Entity info -->

	<link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="loc_dei_EntityRegistrantName" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:type="locator" />
    <link:definitionArc order="11" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="loc_dei_EntityAddressAddressLine1" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:type="locator" />
    <link:definitionArc order="12" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="loc_dei_EntityAddressAddressLine2" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:type="locator" />
    <link:definitionArc order="13" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="loc_dei_EntityAddressCityOrTown" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:type="locator" />
    <link:definitionArc order="14" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="loc_dei_EntityAddressStateOrProvince" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="loc_dei_EntityAddressCountry" xlink:type="locator" />
    <link:definitionArc order="15" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="loc_dei_EntityAddressCountry" xlink:type="arc" />
	<link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:type="locator" />
    <link:definitionArc order="16" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="loc_dei_EntityAddressPostalZipCode" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:type="locator" />
    <link:definitionArc order="17" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="loc_dei_EntityIncorporationStateCountryCode" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="loc_dei_CountryRegion" xlink:type="locator" />
    <link:definitionArc order="18" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="loc_dei_CountryRegion" xlink:type="arc" />
	<link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode" xlink:type="locator" />
    <link:definitionArc order="19" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="loc_dei_CityAreaCode" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber" xlink:type="locator" />
    <link:definitionArc order="20" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="loc_dei_LocalPhoneNumber" xlink:type="arc" />
	<link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber" xlink:type="locator" />
    <link:definitionArc order="21" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="loc_dei_EntityFileNumber" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey" xlink:type="locator" />
    <link:definitionArc order="22" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="loc_dei_EntityCentralIndexKey" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:type="locator" />
    <link:definitionArc order="23" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="loc_dei_EntityEmergingGrowthCompany" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:type="locator" />
    <link:definitionArc order="24" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="loc_dei_EntityTaxIdentificationNumber" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInformationFormerLegalOrRegisteredName" xlink:label="loc_dei_EntityInformationFormerLegalOrRegisteredName" xlink:type="locator" />
    <link:definitionArc order="25" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="loc_dei_EntityInformationFormerLegalOrRegisteredName" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_dei_EntityExTransitionPeriod" xlink:type="locator" />
    <link:definitionArc order="26" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="loc_dei_EntityExTransitionPeriod" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="loc_dei_WrittenCommunications" xlink:type="locator" />
    <link:definitionArc order="27" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="loc_dei_WrittenCommunications" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="loc_dei_SolicitingMaterial" xlink:type="locator" />
    <link:definitionArc order="28" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="loc_dei_SolicitingMaterial" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:type="locator" />
    <link:definitionArc order="29" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="loc_dei_PreCommencementTenderOffer" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:type="locator" />
    <link:definitionArc order="30" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="loc_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:type="locator" />
    <link:definitionArc order="31" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="loc_dei_CurrentFiscalYearEndDate" xlink:type="arc" />

	<!-- Securities Info -->

    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle" xlink:type="locator" />
    <link:definitionArc order="32" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="loc_dei_Security12bTitle" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol" xlink:type="locator" />
    <link:definitionArc order="33" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="loc_dei_TradingSymbol" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName" xlink:type="locator" />
    <link:definitionArc order="34" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="loc_dei_SecurityExchangeName" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="loc_dei_Security12gTitle" xlink:type="locator" />
    <link:definitionArc order="35" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="loc_dei_Security12gTitle" xlink:type="arc" />

  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>mdcx-20250821_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<!-- Generated by Newsfile Corp. (www.newsfilecorp.com) -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
	<link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document and Entity Information [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="loc_dei_CoverAbstract" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" />
	<link:label id="lab_dei_DocumentInformationTable_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
    <link:label id="lab_dei_DocumentInformationTable_label_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentInformationTable" xlink:label="loc_dei_DocumentInformationTable" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationTable" xlink:to="lab_dei_DocumentInformationTable" xlink:type="arc" />

	<!-- Address Axis -->

	<link:label id="lab_dei_EntityAddressesAddressTypeAxis_terseLabel_en-US" xlink:label="lab_dei_EntityAddressesAddressTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">ntity Addresses, Address Type [Axis]</link:label>
    <link:label id="lab_dei_EntityAddressesAddressTypeAxis_label_en-US" xlink:label="lab_dei_EntityAddressesAddressTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ntity Addresses, Address Type [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="loc_dei_EntityAddressesAddressTypeAxis" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressesAddressTypeAxis" xlink:to="lab_dei_EntityAddressesAddressTypeAxis" xlink:type="arc" />
	<link:label id="loc_dei_AddressTypeDomain_terseLabel_en-US" xlink:label="lab_dei_AddressTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Address Type [Domain]</link:label>
    <link:label id="loc_dei_AddressTypeDomain_label_en-US" xlink:label="lab_dei_AddressTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Address Type [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AddressTypeDomain" xlink:label="loc_dei_AddressTypeDomain" xlink:type="locator" />
	<link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AddressTypeDomain" xlink:to="lab_dei_AddressTypeDomain" xlink:type="arc" />
    <link:label id="lab_dei_FormerAddressMember_terseLabel_en-US" xlink:label="lab_dei_FormerAddressMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Former Address [Member]</link:label>
    <link:label id="lab_dei_FormerAddressMember_label_en-US" xlink:label="lab_dei_FormerAddressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Former Address [Member]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_FormerAddressMember" xlink:label="loc_dei_FormerAddressMember" xlink:type="locator" />
	<link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_FormerAddressMember" xlink:to="lab_dei_FormerAddressMember" xlink:type="arc" />

	<!-- Exchange Axis -->

	<link:label id="lab_dei_EntityListingsExchangeAxis_terseLabel_en-US" xlink:label="lab_dei_EntityListingsExchangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Listings, Exchange [Axis]</link:label>
    <link:label id="lab_dei_EntityListingsExchangeAxis_label_en-US" xlink:label="lab_dei_EntityListingsExchangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Listings, Exchange [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityListingsExchangeAxis" xlink:label="loc_dei_EntityListingsExchangeAxis" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityListingsExchangeAxis" xlink:to="lab_dei_EntityListingsExchangeAxis" xlink:type="arc" />
	<link:label id="loc_dei_ExchangeDomain_terseLabel_en-US" xlink:label="lab_dei_ExchangeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exchange [Domain]</link:label>
    <link:label id="loc_dei_ExchangeDomain_label_en-US" xlink:label="lab_dei_ExchangeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exchange [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_ExchangeDomain" xlink:label="loc_dei_ExchangeDomain" xlink:type="locator" />
	<link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_ExchangeDomain" xlink:to="lab_dei_ExchangeDomain" xlink:type="arc" />
    <link:label id="lab_exch_XNYS_terseLabel_en-US" xlink:label="lab_exch_XNYS" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">New York Stock Exchange [Member]</link:label>
    <link:label id="lab_exch_XNYS_label_en-US" xlink:label="lab_exch_XNYS" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New York Stock Exchange [Member]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/exch/2025/exch-2025.xsd#exch_XNYS" xlink:label="loc_exch_XNYS" xlink:type="locator" />
	<link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exch_XNYS" xlink:to="lab_exch_XNYS" xlink:type="arc" />
	<link:label id="lab_exch_XNAS_terseLabel_en-US" xlink:label="lab_exch_XNAS" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">NASDAQ [Member]</link:label>
    <link:label id="lab_exch_XNAS_label_en-US" xlink:label="lab_exch_XNAS" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">NASDAQ [Member]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/exch/2025/exch-2025.xsd#exch_XNAS" xlink:label="loc_exch_XNAS" xlink:type="locator" />
	<link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exch_XNAS" xlink:to="lab_exch_XNAS" xlink:type="arc" />
	<link:label id="lab_exch_XNGS_terseLabel_en-US" xlink:label="lab_exch_XNGS" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">NASDAQ Global Select Market [Member]</link:label>
    <link:label id="lab_exch_XNGS_label_en-US" xlink:label="lab_exch_XNGS" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">NASDAQ Global Select Market [Member]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/exch/2025/exch-2025.xsd#exch_XNGS" xlink:label="loc_exch_XNGS" xlink:type="locator" />
	<link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exch_XNGS" xlink:to="lab_exch_XNGS" xlink:type="arc" />
	<link:label id="lab_exch_XTSX_terseLabel_en-US" xlink:label="lab_exch_XTSX" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Toronto Stock Exchange [Member]</link:label>
    <link:label id="lab_exch_XTSX_label_en-US" xlink:label="lab_exch_XTSX" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Toronto Stock Exchange [Member]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/exch/2025/exch-2025.xsd#exch_XTSX" xlink:label="loc_exch_XTSX" xlink:type="locator" />
	<link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exch_XTSX" xlink:to="lab_exch_XTSX" xlink:type="arc" />
	<link:label id="lab_exch_XASE_terseLabel_en-US" xlink:label="lab_exch_XASE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">NYSE MKT LLC [Member]</link:label>
    <link:label id="lab_exch_XASE_label_en-US" xlink:label="lab_exch_XASE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">NYSE MKT LLC [Member]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/exch/2025/exch-2025.xsd#exch_XASE" xlink:label="loc_exch_XASE" xlink:type="locator" />
	<link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exch_XASE" xlink:to="lab_exch_XASE" xlink:type="arc" />
	<link:label id="lab_exch_XNMS_terseLabel_en-US" xlink:label="lab_exch_XNMS" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">NASDAQ Global Market [Member]</link:label>
    <link:label id="lab_exch_XNMS_label_en-US" xlink:label="lab_exch_XNMS" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">NASDAQ Global Market [Member]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/exch/2025/exch-2025.xsd#exch_XNMS" xlink:label="loc_exch_XNMS" xlink:type="locator" />
	<link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exch_XNMS" xlink:to="lab_exch_XNMS" xlink:type="arc" />
	<link:label id="lab_exch_XNCM_terseLabel_en-US" xlink:label="lab_exch_XNCM" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">NASDAQ Capital Market [Member]</link:label>
    <link:label id="lab_exch_XNCM_label_en-US" xlink:label="lab_exch_XNCM" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">NASDAQ Capital Market [Member]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/exch/2025/exch-2025.xsd#exch_XNCM" xlink:label="loc_exch_XNCM" xlink:type="locator" />
	<link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exch_XNCM" xlink:to="lab_exch_XNCM" xlink:type="arc" />

	<!-- Class of Stock Axis -->

	<link:label id="lab_us-gaap_StatementClassOfStockAxis_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:type="locator" />
	<link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" />
	<link:label id="lab_us-gaap_ClassOfStockDomain_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:type="locator" />
	<link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" />
	<link:label id="lab_us-gaap_CommonStockMember_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember" xlink:type="locator" />
	<link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" />
	<link:label id="lab_us-gaap_CommonClassAMember_terseLabel_en-US" xlink:label="lab_us-gaap_CommonClassAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock Class A [Member]</link:label>
    <link:label id="lab_us-gaap_CommonClassAMember_label_en-US" xlink:label="lab_us-gaap_CommonClassAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock Class A [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaap_CommonClassAMember" xlink:type="locator" />
	<link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonClassAMember" xlink:to="lab_us-gaap_CommonClassAMember" xlink:type="arc" />
	<link:label id="lab_us-gaap_CommonClassBMember_terseLabel_en-US" xlink:label="lab_us-gaap_CommonClassBMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock Class B [Member]</link:label>
    <link:label id="lab_us-gaap_CommonClassBMember_label_en-US" xlink:label="lab_us-gaap_CommonClassBMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock Class B [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaap_CommonClassBMember" xlink:type="locator" />
	<link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonClassBMember" xlink:to="lab_us-gaap_CommonClassBMember" xlink:type="arc" />
	<link:label id="lab_us-gaap_PreferredStockMember_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred Stock [Member]</link:label>
    <link:label id="lab_us-gaap_PreferredStockMember_label_en-US" xlink:label="lab_us-gaap_PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaap_PreferredStockMember" xlink:type="locator" />
	<link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockMember" xlink:to="lab_us-gaap_PreferredStockMember" xlink:type="arc" />
	<link:label id="lab_mdcx_CommonSharesNoParValueMember_terseLabel_en-US" xlink:label="lab_mdcx_CommonSharesNoParValueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common shares, no par value [Member]</link:label>
	<link:label id="lab_mdcx_CommonSharesNoParValueMember_label_en-US" xlink:label="lab_mdcx_CommonSharesNoParValueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common shares, no par value [Member]</link:label>
	<link:loc xlink:href="mdcx-20250821.xsd#mdcx_CommonSharesNoParValueMember" xlink:label="loc_mdcx_CommonSharesNoParValueMember" xlink:type="locator" />
	<link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdcx_CommonSharesNoParValueMember" xlink:to="lab_mdcx_CommonSharesNoParValueMember" xlink:type="arc" />
	<link:label id="lab_mdcx_WarrantsEachExercisableForOneCommonShareAtAnExercisePriceOfFourPointSixFourPerShareMember_terseLabel_en-US" xlink:label="lab_mdcx_WarrantsEachExercisableForOneCommonShareAtAnExercisePriceOfFourPointSixFourPerShareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrants, each exercisable for one common share at an exercise price of $4.64 per share [Member]</link:label>
	<link:label id="lab_mdcx_WarrantsEachExercisableForOneCommonShareAtAnExercisePriceOfFourPointSixFourPerShareMember_label_en-US" xlink:label="lab_mdcx_WarrantsEachExercisableForOneCommonShareAtAnExercisePriceOfFourPointSixFourPerShareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrants, each exercisable for one common share at an exercise price of $4.64 per share [Member]</link:label>
	<link:loc xlink:href="mdcx-20250821.xsd#mdcx_WarrantsEachExercisableForOneCommonShareAtAnExercisePriceOfFourPointSixFourPerShareMember" xlink:label="loc_mdcx_WarrantsEachExercisableForOneCommonShareAtAnExercisePriceOfFourPointSixFourPerShareMember" xlink:type="locator" />
	<link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdcx_WarrantsEachExercisableForOneCommonShareAtAnExercisePriceOfFourPointSixFourPerShareMember" xlink:to="lab_mdcx_WarrantsEachExercisableForOneCommonShareAtAnExercisePriceOfFourPointSixFourPerShareMember" xlink:type="arc" />


	<!-- Everything else -->

	<link:label id="lab_dei_DocumentInformationLineItems_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:label id="lab_dei_DocumentInformationLineItems_label_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentInformationLineItems" xlink:label="loc_dei_DocumentInformationLineItems" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="lab_dei_DocumentInformationLineItems" xlink:type="arc" />
	<link:label id="lab_dei_EntityRegistrantName_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" />
    <link:label id="lab_dei_EntityAddressAddressLine1_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" />
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State Country Name</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State Country Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" />
    <link:label id="lab_dei_DocumentType_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" />
	<link:label id="lab_dei_Security12bTitle_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" />
	<link:label id="lab_dei_Security12gTitle_terseLabel_en-US" xlink:label="lab_dei_Security12gTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(g) Security</link:label>
    <link:label id="lab_dei_Security12gTitle_label_en-US" xlink:label="lab_dei_Security12gTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(g) Security</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="loc_dei_Security12gTitle" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12gTitle" xlink:to="lab_dei_Security12gTitle" xlink:type="arc" />
	<link:label id="lab_dei_SecurityExchangeName_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" />
	<link:label id="lab_dei_TradingSymbol_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" />
    <link:label id="lab_dei_DocumentCreationDate_terseLabel_en-US" xlink:label="lab_dei_DocumentCreationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Creation Date</link:label>
    <link:label id="lab_dei_DocumentCreationDate_label_en-US" xlink:label="lab_dei_DocumentCreationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Creation Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentCreationDate" xlink:label="loc_dei_DocumentCreationDate" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentCreationDate" xlink:to="lab_dei_DocumentCreationDate" xlink:type="arc" />
    <link:label id="lab_dei_LocalPhoneNumber_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" />
    <link:label id="lab_dei_EntityFileNumber_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" />
    <link:label id="lab_dei_EntityAddressPostalZipCode_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" />
    <link:label id="lab_dei_EntityCentralIndexKey_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" />
    <link:label id="lab_dei_DocumentPeriodEndDate_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" />
    <link:label id="lab_dei_DocumentFiscalYearFocus_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" />
	<link:label id="lab_dei_AmendmentFlag_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag" xlink:type="locator" />
	<link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" />
	<link:label id="lab_dei_AmendmentDescription_terseLabel_en-US" xlink:label="lab_dei_AmendmentDescription" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Description</link:label>
    <link:label id="lab_dei_AmendmentDescription_label_en-US" xlink:label="lab_dei_AmendmentDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Description</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="loc_dei_AmendmentDescription" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentDescription" xlink:to="lab_dei_AmendmentDescription" xlink:type="arc" />
    <link:label id="lab_dei_NoTradingSymbolFlag_terseLabel_en-US" xlink:label="lab_dei_NoTradingSymbolFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">No Trading Symbol Flag</link:label>
    <link:label id="lab_dei_NoTradingSymbolFlag_label_en-US" xlink:label="lab_dei_NoTradingSymbolFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">No Trading Symbol Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_dei_NoTradingSymbolFlag" xlink:type="locator" />
	<link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_NoTradingSymbolFlag" xlink:to="lab_dei_NoTradingSymbolFlag" xlink:type="arc" />
    <link:label id="lab_dei_EntityEmergingGrowthCompany_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" />
    <link:label id="lab_dei_EntityTaxIdentificationNumber_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" />
    <link:label id="lab_dei_EntityInformationFormerLegalOrRegisteredName_terseLabel_en-US" xlink:label="lab_dei_EntityInformationFormerLegalOrRegisteredName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Information, Former Legal or Registered Name</link:label>
    <link:label id="lab_dei_EntityInformationFormerLegalOrRegisteredName_label_en-US" xlink:label="lab_dei_EntityInformationFormerLegalOrRegisteredName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Information, Former Legal or Registered Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInformationFormerLegalOrRegisteredName" xlink:label="loc_dei_EntityInformationFormerLegalOrRegisteredName" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInformationFormerLegalOrRegisteredName" xlink:to="lab_dei_EntityInformationFormerLegalOrRegisteredName" xlink:type="arc" />
    <link:label id="lab_dei_EntityExTransitionPeriod_terseLabel_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:label id="lab_dei_EntityExTransitionPeriod_label_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_dei_EntityExTransitionPeriod" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityExTransitionPeriod" xlink:to="lab_dei_EntityExTransitionPeriod" xlink:type="arc" />
    <link:label id="lab_dei_CityAreaCode_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" />
    <link:label id="lab_dei_CountryRegion_terseLabel_en-US" xlink:label="lab_dei_CountryRegion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Region code of country</link:label>
    <link:label id="lab_dei_CountryRegion_label_en-US" xlink:label="lab_dei_CountryRegion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Region code of country</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="loc_dei_CountryRegion" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CountryRegion" xlink:to="lab_dei_CountryRegion" xlink:type="arc" />
	<link:label id="lab_dei_EntityAddressAddressLine2_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" />
    <link:label id="lab_dei_EntityAddressCityOrTown_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" />
    <link:label id="lab_dei_EntityAddressStateOrProvince_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" />
    <link:label id="lab_dei_EntityAddressCountry_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Country</link:label>
    <link:label id="lab_dei_EntityAddressCountry_label_en-US" xlink:label="lab_dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Country</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="loc_dei_EntityAddressCountry" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCountry" xlink:to="lab_dei_EntityAddressCountry" xlink:type="arc" />
    <link:label id="lab_dei_WrittenCommunications_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="loc_dei_WrittenCommunications" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" />
    <link:label id="lab_dei_SolicitingMaterial_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="loc_dei_SolicitingMaterial" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" />
    <link:label id="lab_dei_PreCommencementTenderOffer_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" />
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" />
    <link:label id="lab_dei_CurrentFiscalYearEndDate_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>mdcx-20250821_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<!-- Generated by Newsfile Corp. (www.newsfilecorp.com) -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.medicuspharma.com/role/DocumentAndEntityInformationDocument" xlink:href="mdcx-20250821.xsd#DocumentAndEntityInformationDocument" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:presentationLink xlink:role="http://www.medicuspharma.com/role/DocumentAndEntityInformationDocument" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="loc_dei_CoverAbstract" xlink:type="locator" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentInformationTable" xlink:label="loc_dei_DocumentInformationTable" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract" xlink:to="loc_dei_DocumentInformationTable" xlink:type="arc" />

	<!-- Address Axis -->

	<link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="loc_dei_EntityAddressesAddressTypeAxis" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable" xlink:to="loc_dei_EntityAddressesAddressTypeAxis" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AddressTypeDomain" xlink:label="loc_dei_AddressTypeDomain" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesAddressTypeAxis" xlink:to="loc_dei_AddressTypeDomain" xlink:type="arc" />
	<link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_FormerAddressMember" xlink:label="loc_dei_FormerAddressMember" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_AddressTypeDomain" xlink:to="loc_dei_FormerAddressMember" xlink:type="arc" />

	<!-- Exchange Axis -->

	<link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityListingsExchangeAxis" xlink:label="loc_dei_EntityListingsExchangeAxis" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable" xlink:to="loc_dei_EntityListingsExchangeAxis" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_ExchangeDomain" xlink:label="loc_dei_ExchangeDomain" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityListingsExchangeAxis" xlink:to="loc_dei_ExchangeDomain" xlink:type="arc" />
	<link:loc xlink:href="https://xbrl.sec.gov/exch/2025/exch-2025.xsd#exch_XNYS" xlink:label="loc_exch_XNYS" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_ExchangeDomain" xlink:to="loc_exch_XNYS" xlink:type="arc" />
	<link:loc xlink:href="https://xbrl.sec.gov/exch/2025/exch-2025.xsd#exch_XNAS" xlink:label="loc_exch_XNAS" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_ExchangeDomain" xlink:to="loc_exch_XNAS" xlink:type="arc" />
	<link:loc xlink:href="https://xbrl.sec.gov/exch/2025/exch-2025.xsd#exch_XNGS" xlink:label="loc_exch_XNGS" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_ExchangeDomain" xlink:to="loc_exch_XNGS" xlink:type="arc" />
	<link:loc xlink:href="https://xbrl.sec.gov/exch/2025/exch-2025.xsd#exch_XTSX" xlink:label="loc_exch_XTSX" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_ExchangeDomain" xlink:to="loc_exch_XTSX" xlink:type="arc" />
	<link:loc xlink:href="https://xbrl.sec.gov/exch/2025/exch-2025.xsd#exch_XASE" xlink:label="loc_exch_XASE" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_ExchangeDomain" xlink:to="loc_exch_XASE" xlink:type="arc" />
	<link:loc xlink:href="https://xbrl.sec.gov/exch/2025/exch-2025.xsd#exch_XNMS" xlink:label="loc_exch_XNMS" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_ExchangeDomain" xlink:to="loc_exch_XNMS" xlink:type="arc" />
	<link:loc xlink:href="https://xbrl.sec.gov/exch/2025/exch-2025.xsd#exch_XNCM" xlink:label="loc_exch_XNCM" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_ExchangeDomain" xlink:to="loc_exch_XNCM" xlink:type="arc" />

	<!-- Class of Stock Axis -->

	<link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable" xlink:to="loc_us-gaap_StatementClassOfStockAxis" xlink:type="arc" />
	<link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="loc_us-gaap_ClassOfStockDomain" xlink:type="arc" />
	<link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="loc_us-gaap_CommonStockMember" xlink:type="arc" />
	<link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaap_CommonClassAMember" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="loc_us-gaap_CommonClassAMember" xlink:type="arc" />
	<link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaap_CommonClassBMember" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="loc_us-gaap_CommonClassBMember" xlink:type="arc" />
	<link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaap_PreferredStockMember" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="loc_us-gaap_PreferredStockMember" xlink:type="arc" />
	<link:loc xlink:href="mdcx-20250821.xsd#mdcx_CommonSharesNoParValueMember" xlink:label="loc_mdcx_CommonSharesNoParValueMember" xlink:type="locator" />
	<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="loc_mdcx_CommonSharesNoParValueMember" xlink:type="arc" />
	<link:loc xlink:href="mdcx-20250821.xsd#mdcx_WarrantsEachExercisableForOneCommonShareAtAnExercisePriceOfFourPointSixFourPerShareMember" xlink:label="loc_mdcx_WarrantsEachExercisableForOneCommonShareAtAnExercisePriceOfFourPointSixFourPerShareMember" xlink:type="locator" />
	<link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="loc_mdcx_WarrantsEachExercisableForOneCommonShareAtAnExercisePriceOfFourPointSixFourPerShareMember" xlink:type="arc" />


    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentInformationLineItems" xlink:label="loc_dei_DocumentInformationLineItems" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable" xlink:to="loc_dei_DocumentInformationLineItems" xlink:type="arc" />

	<!-- Document info -->

    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="loc_dei_DocumentType" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentCreationDate" xlink:label="loc_dei_DocumentCreationDate" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="loc_dei_DocumentCreationDate" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="loc_dei_DocumentPeriodEndDate" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="loc_dei_DocumentFiscalYearFocus" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="loc_dei_AmendmentFlag" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="loc_dei_AmendmentDescription" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="loc_dei_AmendmentDescription" xlink:type="arc" />
	<link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_dei_NoTradingSymbolFlag" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="loc_dei_NoTradingSymbolFlag" xlink:type="arc" />

	<!-- Entity info -->

	<link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="loc_dei_EntityRegistrantName" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="loc_dei_EntityAddressAddressLine1" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="loc_dei_EntityAddressAddressLine2" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="loc_dei_EntityAddressCityOrTown" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="loc_dei_EntityAddressStateOrProvince" xlink:type="arc" />
	<link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="loc_dei_EntityAddressCountry" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="loc_dei_EntityAddressCountry" xlink:type="arc" />
	<link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="loc_dei_EntityAddressPostalZipCode" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="loc_dei_EntityIncorporationStateCountryCode" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode" xlink:type="locator" />
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="loc_dei_CityAreaCode" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="loc_dei_CountryRegion" xlink:type="locator" />
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="loc_dei_CountryRegion" xlink:type="arc" />
	<link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber" xlink:type="locator" />
    <link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="loc_dei_LocalPhoneNumber" xlink:type="arc" />
	<link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber" xlink:type="locator" />
    <link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="loc_dei_EntityFileNumber" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey" xlink:type="locator" />
    <link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="loc_dei_EntityCentralIndexKey" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:type="locator" />
    <link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="loc_dei_EntityEmergingGrowthCompany" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:type="locator" />
    <link:presentationArc order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="loc_dei_EntityTaxIdentificationNumber" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInformationFormerLegalOrRegisteredName" xlink:label="loc_dei_EntityInformationFormerLegalOrRegisteredName" xlink:type="locator" />
    <link:presentationArc order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="loc_dei_EntityInformationFormerLegalOrRegisteredName" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_dei_EntityExTransitionPeriod" xlink:type="locator" />
    <link:presentationArc order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="loc_dei_EntityExTransitionPeriod" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="loc_dei_WrittenCommunications" xlink:type="locator" />
    <link:presentationArc order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="loc_dei_WrittenCommunications" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="loc_dei_SolicitingMaterial" xlink:type="locator" />
    <link:presentationArc order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="loc_dei_SolicitingMaterial" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:type="locator" />
    <link:presentationArc order="27" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="loc_dei_PreCommencementTenderOffer" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:type="locator" />
    <link:presentationArc order="28" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="loc_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:type="locator" />
    <link:presentationArc order="29" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="loc_dei_CurrentFiscalYearEndDate" xlink:type="arc" />

	<!-- Securities info -->

    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle" xlink:type="locator" />
    <link:presentationArc order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="loc_dei_Security12bTitle" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol" xlink:type="locator" />
    <link:presentationArc order="31" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="loc_dei_TradingSymbol" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName" xlink:type="locator" />
    <link:presentationArc order="32" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="loc_dei_SecurityExchangeName" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="loc_dei_Security12gTitle" xlink:type="locator" />
    <link:presentationArc order="33" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="loc_dei_Security12gTitle" xlink:type="arc" />

 </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>exhibit99-1x001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit99-1x001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  0" P,# @0# P,$! 0$!0D&!04%
M!0L(" 8)#0L-#0T+# P.$!01#@\3#PP,$A@2$Q46%Q<7#A$9&QD6&A06%Q;_
MVP!# 00$! 4%!0H&!@H6#PP/%A86%A86%A86%A86%A86%A86%A86%A86%A86
M%A86%A86%A86%A86%A86%A86%A86%A;_P  1" !> 70# 2(  A$! Q$!_\0
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M8] TR]2P7;;QR+)(,AB693U*O@?[)K[DTB5YM)M9I#EY($9CZDJ":_.CXC>
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M67V-%ZO;\-1SJ*O"$%]K5^BW_P B'_@J+!#:_#GP/;6\2Q0PZ[LC1!A540,
M /3%?4.@_P#(#LO^O:/_ -!%?,7_  50_P"1#\%_]C ?_1+5].Z#_P @.R_Z
M]H__ $$5S8C_ '&AZR_-&M+_ 'FI\CYL_P""J8!^!ND@G .LKD^G[IZH^'OC
M_P#'.UT"QM;?]G+4IX8;6...47,P\Q0H ;_4]P,U=_X*K?\ )"M*_P"PPO\
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M%E+MB8_,^'R65LPI_/\ )FM^W/X]ATGPA'X*LIC]OU8"2YV_\LH >A]V(Q]
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M@[QW:VL7C#0[75(K"0RP"XSB)B,$C!]*U+?Q%X?GF6&#7--DD<X5$NXV8GV
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M4-?U>ST^WC7+/<2A?R!Y/X5\>_M=_M'Z3XRTB;PCX/TR&XT]CB;5+VV!9_\
MKBC#*C_:.#Z =:^?O$&KZKJ]TUQJNI7=]*3DO<3-(<_4FLB;^M-U7(\3'\35
ML5%TJ4>6+^;_ . 5I?O&JTE7[6TNK^^2TLK::YN)F"QQ0H7=R>@ ')-?27P"
M_9!US7&M]8^(\TFCV!(<:;$0;J4>CGI'G\3]*J*N<&!P5?%2Y:4;_D;?_!+3
MP;?PR^(?'5W T=K<0II]BQ_Y:D-OE(]AA!GUSZ5]B50\,:+I7AW0;;1=$L8K
M*PLXQ'!!$,*BC^?U/-7ZV6A^D8'"K"X>-*][!1113.L**** "BBB@ HHHH *
MR?'G_(CZS_V#Y_\ T6U:U9GC2*6?P?JT$$;22R6,RHBC)9BA  'K50^)"ELS
MPKX<VG[/L_P!T5/%,'@AIO[%B-Z9%M_M ?RQDY'S[\^G.:]*_9A?5W^!^A-K
M+WKS&)_(:^S]H:WWMY)DSSN\O9G/-0? SP)H%E\*?#']I^$M.AU2#3(/M!GL
M$$R2A!G=D9W9KT4# P!79BJ\9<T%=ZWU?KL8TJ=K2\CS7]K2Z@LO@T][=2>7
M!;ZYH\LKD9VJNI6Q)X]A5S_A=7PS_P"AGC_\!I?_ (FG?M':;?ZM\-%L]-LI
MKR?^W-)E,4*%VV)J%N[M@=E56)]@:[GR8?\ GDG_ 'R*S4J?L(J2;U>SMT7D
MRFI\[L^WZGFO[*-W;:A\.=1OK.026]SXCU.6%P"-RM<N0<'VKTVN"_9XTR_T
MKP?JD&H64UI))XBU&:-)8RI:-[AV5@#V(((K<^*VK:KH?PYUC4]"TNXU/5(;
M5A8VEO&7>69OE08'8,02>P!I5USXB2CU8Z;M35^QXM\1K'4_&GBCQ-\4-(,D
MS?#V:*W\.1Q$CSG@8R7V.Q\P$1_]LZ]\\,:M9Z]X<L-;T^42VNHVT=S X_B1
MU##]#7EOP_\ @]XN\.^#;/2(/C!XCM0L>ZXABT_3G0RO\TA!>W9CEBQY)/-:
M?[->CZWX.TO6/A]JB7D]EX?OC_8VI3Q!5N[24>8 "H"Y1F=2!P,# QBNC$^S
MG3M&2?+MOMMU2ZZ_-F=/FC+5;_G_ %^1Z%K_ /R ;W_KVD_]!-?//P5LO@%<
M?LU^&D\5V_@HW']@P&_,RP?: _EC<21\^_/XYKZ'UM'DT6\C12S-;N%4#))*
MG@5X;X5^$$5_^S+X.^S:!::3XTT'3K6\M)9[-4D6[CCYCF!'S*X+*P;USU -
M3A905-J4FKM;>C*JIMZ*^G^1W'[*9U<_ C13K#7;2;KD6C7F?/-I]HE^S%\\
MY\GR^O.,9YS2_M9-M_9K\:MC[NC3']*ZGX>ZQ=:]X,L-4O\ 2+K2;N:+%S8W
M411[>1259<'J,@X/0C!'6N>_:=T[4-7_ &??%^F:593WM[=:3-'!;P(7DE8C
MA54=341E?&*35O>_4?+^ZMY&-^S3=GP_X?U7X?:C,P_X0^4"SDE;)?3I%\R!
ML^BJ6C_[9UP7P8>[US]JR/X@7C2#_A*]%OWL8G/$5C!/#%;X';<-\G_;2NF^
M/W@SQ9>:AHVI>"[<BXUVR'AW7F'!AM),-YY]X\2#_MI6_'X:FTO]H'PLVFZ9
M,FC:7X3NK%9UC/E1'S8-B%N@)"DX]C72IPM*:>LT[_=K][U,N5W4;:1_K\$>
MF5YC^T5_Q4LV@_"R$L5\57>_52C$%-.@Q),"1VD(2+_@9KTZO%[/P7XQ\8_&
M'Q)XV/B?6_",5HXT;1TM[*V9[BVC :24BXB? >4M@C&0HKDPJ2FYMVM^?3_/
MY&M6[7*EN;_[.5Q)I=AK7PZO9-UWX/OC!"#U>RES);./;82GU0UZ37C4?@_Q
M=X*^-6A^+CXCUKQ;!K$;:/K+3V5NK6\7,D$I%O$@VJ^\$L#@/U KV6EBE'GY
MXN]]?GU_$=*]K-;!1117,:!1110 4444 %%%% !3+B**>!X9XTDCD4JZ.N58
M'J"#UI]% 'A'QG_9LT/Q TNJ>$+A='U @DVK+FVE/H!UC/N,CVKY8^(7A#Q'
MX.U=M.\1Z5/92\[&<9CE'JC#AA]*_1ZLWQ9X?T3Q-HTNE:_IEMJ%G,/FBGC#
M#Z@]01ZCFN*M@H2UCHSYW,>'</B;SH^Y+\'\NGR/S)N/N?@:SKC[WX5]1_'S
M]F:/2+>XUOPCJ\4=DN6:ROBV8_974'(^H_&O"_ ?P[UCQCXG;1=/N[&&6-]C
MO.[A?J,*2>OM7-&G*#Y6?"8K+<3AZWL9KWO4X6;[QKUGX&_LY>-_B-Y=_<1G
M0M%<Y^W7<1+2#_IG'D%OJ<#WKZ<^!?[-/@WP5Y&JZ[''X@UF,AUEGC_<0MZI
M&>"1ZMG\*]N50JA5  '0 =*[J=%]3Z?*^%MJF+?_ &ZOU?\ E]YP'P6^#7@;
MX96@_L'31+?LN)=1N</</ZX/\(]EQ7H%%%="5C[*E1ITH*%.-DNP4444&@44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
<0 4444 %%%% !1110 4444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information Document<br></strong></div></th>
<th class="th"><div>Aug. 21, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentCreationDate', window );">Document Creation Date</a></td>
<td class="text">Aug. 21,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug. 21,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Medicus Pharma Ltd.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">300 Conshohocken State Road, Suite 200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Conshohocken<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">PA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">US<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">19428<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State Country Name</a></td>
<td class="text">A6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">610<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">540-7515<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-42408<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001997296<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">98-1778211<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityListingsExchangeAxis=exch_XNCM', window );">NASDAQ Capital Market [Member] | Common shares, no par value [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common shares, no par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDCX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityListingsExchangeAxis=exch_XNCM', window );">NASDAQ Capital Market [Member] | Warrants, each exercisable for one common share at an exercise price of $4.64 per share [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Warrants, each exercisable for one common share at an exercise price of $4.64 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDCXW<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentCreationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The date the document was made available and submitted, in YYYY-MM-DD format. The date of submission, date of acceptance by the recipient, and the document effective date are all potentially different.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentCreationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityListingsExchangeAxis=exch_XNCM">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityListingsExchangeAxis=exch_XNCM</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mdcx_CommonSharesNoParValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mdcx_CommonSharesNoParValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mdcx_WarrantsEachExercisableForOneCommonShareAtAnExercisePriceOfFourPointSixFourPerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mdcx_WarrantsEachExercisableForOneCommonShareAtAnExercisePriceOfFourPointSixFourPerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>25</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>3</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="form8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001000 - Document - Document and Entity Information Document</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medicuspharma.com/role/DocumentAndEntityInformationDocument</Role>
      <ShortName>Document and Entity Information Document</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="form8k.htm">form8k.htm</File>
    <File>mdcx-20250821.xsd</File>
    <File>mdcx-20250821_cal.xml</File>
    <File>mdcx-20250821_def.xml</File>
    <File>mdcx-20250821_lab.xml</File>
    <File>mdcx-20250821_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="28">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "form8k.htm": {
   "nsprefix": "mdcx",
   "nsuri": "http://www.medicuspharma.com/20250821",
   "dts": {
    "inline": {
     "local": [
      "form8k.htm"
     ]
    },
    "schema": {
     "local": [
      "mdcx-20250821.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/currency/2025/currency-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/exch/2025/exch-2025.xsd",
      "https://xbrl.sec.gov/naics/2025/naics-2025.xsd",
      "https://xbrl.sec.gov/sic/2025/sic-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "mdcx-20250821_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "mdcx-20250821_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "mdcx-20250821_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "mdcx-20250821_pre.xml"
     ]
    }
   },
   "keyStandard": 25,
   "keyCustom": 0,
   "axisStandard": 2,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 2,
   "hidden": {
    "total": 4,
    "http://xbrl.sec.gov/dei/2025": 4
   },
   "contextCount": 3,
   "entityCount": 1,
   "segmentCount": 3,
   "elementCount": 56,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 28
   },
   "report": {
    "R1": {
     "role": "http://www.medicuspharma.com/role/DocumentAndEntityInformationDocument",
     "longName": "0001000 - Document - Document and Entity Information Document",
     "shortName": "Document and Entity Information Document",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "CR20250821",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "CR20250821",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://www.medicuspharma.com/role/DocumentAndEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Address Type [Domain]",
        "label": "Address Type [Domain]",
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://www.medicuspharma.com/role/DocumentAndEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Description",
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.medicuspharma.com/role/DocumentAndEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.medicuspharma.com/role/DocumentAndEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://www.medicuspharma.com/role/DocumentAndEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Domain]",
        "label": "Class of Stock [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonClassAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonClassAMember",
     "presentation": [
      "http://www.medicuspharma.com/role/DocumentAndEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock Class A [Member]",
        "label": "Common Stock Class A [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonClassBMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonClassBMember",
     "presentation": [
      "http://www.medicuspharma.com/role/DocumentAndEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock Class B [Member]",
        "label": "Common Stock Class B [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mdcx_CommonSharesNoParValueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.medicuspharma.com/20250821",
     "localname": "CommonSharesNoParValueMember",
     "presentation": [
      "http://www.medicuspharma.com/role/DocumentAndEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common shares, no par value [Member]",
        "label": "Common shares, no par value [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockMember",
     "presentation": [
      "http://www.medicuspharma.com/role/DocumentAndEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock [Member]",
        "label": "Common Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CountryRegion",
     "presentation": [
      "http://www.medicuspharma.com/role/DocumentAndEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Region code of country",
        "label": "Region code of country",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Document and Entity Information [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://www.medicuspharma.com/role/DocumentAndEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Fiscal Year End Date",
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentCreationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentCreationDate",
     "presentation": [
      "http://www.medicuspharma.com/role/DocumentAndEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Creation Date",
        "label": "Document Creation Date",
        "documentation": "The date the document was made available and submitted, in YYYY-MM-DD format. The date of submission, date of acceptance by the recipient, and the document effective date are all potentially different."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://www.medicuspharma.com/role/DocumentAndEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Year Focus",
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://www.medicuspharma.com/role/DocumentAndEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Information [Line Items]",
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://www.medicuspharma.com/role/DocumentAndEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Information [Table]",
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.medicuspharma.com/role/DocumentAndEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://www.medicuspharma.com/role/DocumentAndEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.medicuspharma.com/role/DocumentAndEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.medicuspharma.com/role/DocumentAndEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line Two",
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.medicuspharma.com/role/DocumentAndEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://www.medicuspharma.com/role/DocumentAndEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Country",
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.medicuspharma.com/role/DocumentAndEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.medicuspharma.com/role/DocumentAndEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://www.medicuspharma.com/role/DocumentAndEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ntity Addresses, Address Type [Axis]",
        "label": "ntity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.medicuspharma.com/role/DocumentAndEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.medicuspharma.com/role/DocumentAndEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://www.medicuspharma.com/role/DocumentAndEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Ex Transition Period",
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.medicuspharma.com/role/DocumentAndEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.medicuspharma.com/role/DocumentAndEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State Country Name",
        "label": "Entity Incorporation, State Country Name",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationFormerLegalOrRegisteredName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInformationFormerLegalOrRegisteredName",
     "presentation": [
      "http://www.medicuspharma.com/role/DocumentAndEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Information, Former Legal or Registered Name",
        "label": "Entity Information, Former Legal or Registered Name",
        "documentation": "Former Legal or Registered Name of an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsExchangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityListingsExchangeAxis",
     "presentation": [
      "http://www.medicuspharma.com/role/DocumentAndEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Listings, Exchange [Axis]",
        "label": "Entity Listings, Exchange [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.medicuspharma.com/role/DocumentAndEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.medicuspharma.com/role/DocumentAndEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_ExchangeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ExchangeDomain",
     "presentation": [
      "http://www.medicuspharma.com/role/DocumentAndEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exchange [Domain]",
        "label": "Exchange [Domain]",
        "documentation": "The set of all exchanges. MIC exchange codes are drawn from ISO 10383."
       }
      }
     },
     "auth_ref": []
    },
    "dei_FormerAddressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "FormerAddressMember",
     "presentation": [
      "http://www.medicuspharma.com/role/DocumentAndEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Former Address [Member]",
        "label": "Former Address [Member]",
        "documentation": "Former address for entity"
       }
      }
     },
     "auth_ref": [
      "r7",
      "r8"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.medicuspharma.com/role/DocumentAndEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://www.medicuspharma.com/role/DocumentAndEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "No Trading Symbol Flag",
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.medicuspharma.com/role/DocumentAndEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.medicuspharma.com/role/DocumentAndEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_PreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockMember",
     "presentation": [
      "http://www.medicuspharma.com/role/DocumentAndEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred Stock [Member]",
        "label": "Preferred Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.medicuspharma.com/role/DocumentAndEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12gTitle",
     "presentation": [
      "http://www.medicuspharma.com/role/DocumentAndEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(g) Security",
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.medicuspharma.com/role/DocumentAndEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.medicuspharma.com/role/DocumentAndEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://www.medicuspharma.com/role/DocumentAndEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Axis]",
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.medicuspharma.com/role/DocumentAndEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "mdcx_WarrantsEachExercisableForOneCommonShareAtAnExercisePriceOfFourPointSixFourPerShareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.medicuspharma.com/20250821",
     "localname": "WarrantsEachExercisableForOneCommonShareAtAnExercisePriceOfFourPointSixFourPerShareMember",
     "presentation": [
      "http://www.medicuspharma.com/role/DocumentAndEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants, each exercisable for one common share at an exercise price of $4.64 per share [Member]",
        "label": "Warrants, each exercisable for one common share at an exercise price of $4.64 per share [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.medicuspharma.com/role/DocumentAndEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "exch_XASE": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/exch/2025",
     "localname": "XASE",
     "presentation": [
      "http://www.medicuspharma.com/role/DocumentAndEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "NYSE MKT LLC [Member]",
        "label": "NYSE MKT LLC [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "exch_XNAS": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/exch/2025",
     "localname": "XNAS",
     "presentation": [
      "http://www.medicuspharma.com/role/DocumentAndEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "NASDAQ [Member]",
        "label": "NASDAQ [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "exch_XNCM": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/exch/2025",
     "localname": "XNCM",
     "presentation": [
      "http://www.medicuspharma.com/role/DocumentAndEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "NASDAQ Capital Market [Member]",
        "label": "NASDAQ Capital Market [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "exch_XNGS": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/exch/2025",
     "localname": "XNGS",
     "presentation": [
      "http://www.medicuspharma.com/role/DocumentAndEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "NASDAQ Global Select Market [Member]",
        "label": "NASDAQ Global Select Market [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "exch_XNMS": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/exch/2025",
     "localname": "XNMS",
     "presentation": [
      "http://www.medicuspharma.com/role/DocumentAndEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "NASDAQ Global Market [Member]",
        "label": "NASDAQ Global Market [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "exch_XNYS": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/exch/2025",
     "localname": "XNYS",
     "presentation": [
      "http://www.medicuspharma.com/role/DocumentAndEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "New York Stock Exchange [Member]",
        "label": "New York Stock Exchange [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "exch_XTSX": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/exch/2025",
     "localname": "XTSX",
     "presentation": [
      "http://www.medicuspharma.com/role/DocumentAndEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Toronto Stock Exchange [Member]",
        "label": "Toronto Stock Exchange [Member]"
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "249",
   "Section": "308",
   "Subsection": "a"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 8-K",
   "Number": "249",
   "Section": "308"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001062993-25-014806-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001062993-25-014806-xbrl.zip
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MD,VSQ=+-Y)_E;#&W&CY]@+A$PU\P0[QY;M@%U]_N%A)59:A0R4(N//#B234
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M'IKL\3$09Z<BE)[K>L2F\!U\%IP/Q_"P@*<WG:[H4)@FXZ+/L#CZ(Z9A!?I
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M=#DY+3$N:'1M4$L! A0#%     @ Y(,66U9:B:9L%P  ;8L   H
M     ( !_A8  &9O<FTX:RYH=&U02P$"% ,4    " #D@Q9;D[0%>1($  #-
M$P  $0              @ &2+@  ;61C>"TR,#(U,#@R,2YX<V102P$"% ,4
M    " #D@Q9;<22[0DD!  #$ @  %0              @ '3,@  ;61C>"TR
M,#(U,#@R,5]C86PN>&UL4$L! A0#%     @ Y(,66_[3ZQWQ!P  X5H  !4
M             ( !3S0  &UD8W@M,C R-3 X,C%?9&5F+GAM;%!+ 0(4 Q0
M   ( .2#%EMC7^H:'0\  '2_   5              "  7,\  !M9&-X+3(P
M,C4P.#(Q7VQA8BYX;6Q02P$"% ,4    " #D@Q9;=C&[YMP'  "R90  %0
M            @ '#2P  ;61C>"TR,#(U,#@R,5]P<F4N>&UL4$L%!@     '
-  < P $  -)3      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>form8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:exch="http://xbrl.sec.gov/exch/2025"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:mdcx="http://www.medicuspharma.com/20250821"
  xmlns:us-gaap="http://fasb.org/us-gaap/2025"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="mdcx-20250821.xsd" xlink:type="simple"/>
    <context id="CR20250821">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
        </entity>
        <period>
            <startDate>2025-08-21</startDate>
            <endDate>2025-08-21</endDate>
        </period>
    </context>
    <context id="CR20250821_dei_EntityListingsExchangeAxis_exch_XNCM_us-gaap_StatementClassOfStockAxis_mdcx_CommonSharesNoParValueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdcx:CommonSharesNoParValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNCM</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-21</startDate>
            <endDate>2025-08-21</endDate>
        </period>
    </context>
    <context id="CR20250821_dei_EntityListingsExchangeAxis_exch_XNCM_us-gaap_StatementClassOfStockAxis_mdcx_WarrantsEachExercisableForOneCommonShareAtAnExercisePriceOfFourPointSixFourPerShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001997296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdcx:WarrantsEachExercisableForOneCommonShareAtAnExercisePriceOfFourPointSixFourPerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNCM</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-21</startDate>
            <endDate>2025-08-21</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="CR20250821" id="ixv-253">false</dei:AmendmentFlag>
    <dei:DocumentPeriodEndDate contextRef="CR20250821" id="ixv-254">2025-08-21</dei:DocumentPeriodEndDate>
    <dei:EntityCentralIndexKey contextRef="CR20250821" id="ixv-255">0001997296</dei:EntityCentralIndexKey>
    <dei:EntityRegistrantName contextRef="CR20250821" id="EntityRegistrantName">Medicus Pharma Ltd.</dei:EntityRegistrantName>
    <dei:DocumentType contextRef="CR20250821" id="ixv-284">8-K</dei:DocumentType>
    <dei:DocumentCreationDate contextRef="CR20250821" id="ixv-285">2025-08-21</dei:DocumentCreationDate>
    <dei:EntityIncorporationStateCountryCode contextRef="CR20250821" id="ixv-286">A6</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="CR20250821" id="ixv-287">001-42408</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="CR20250821" id="ixv-288">98-1778211</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="CR20250821" id="ixv-289">300 Conshohocken State Road, Suite 200</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="CR20250821" id="ixv-290">Conshohocken</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="CR20250821" id="ixv-291">PA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressCountry contextRef="CR20250821" id="ixv-292">US</dei:EntityAddressCountry>
    <dei:EntityAddressPostalZipCode contextRef="CR20250821" id="ixv-293">19428</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="CR20250821" id="ixv-294">610</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="CR20250821" id="ixv-295">540-7515</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="CR20250821" id="ixv-296">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="CR20250821" id="ixv-297">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="CR20250821" id="ixv-298">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="CR20250821" id="ixv-299">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="CR20250821_dei_EntityListingsExchangeAxis_exch_XNCM_us-gaap_StatementClassOfStockAxis_mdcx_CommonSharesNoParValueMember"
      id="ixv-300">Common shares, no par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="CR20250821_dei_EntityListingsExchangeAxis_exch_XNCM_us-gaap_StatementClassOfStockAxis_mdcx_CommonSharesNoParValueMember"
      id="ixv-301">MDCX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="CR20250821_dei_EntityListingsExchangeAxis_exch_XNCM_us-gaap_StatementClassOfStockAxis_mdcx_CommonSharesNoParValueMember"
      id="ixv-302">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="CR20250821_dei_EntityListingsExchangeAxis_exch_XNCM_us-gaap_StatementClassOfStockAxis_mdcx_WarrantsEachExercisableForOneCommonShareAtAnExercisePriceOfFourPointSixFourPerShareMember"
      id="ixv-303">Warrants, each exercisable for one common share at an exercise price of $4.64 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="CR20250821_dei_EntityListingsExchangeAxis_exch_XNCM_us-gaap_StatementClassOfStockAxis_mdcx_WarrantsEachExercisableForOneCommonShareAtAnExercisePriceOfFourPointSixFourPerShareMember"
      id="ixv-304">MDCXW</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="CR20250821_dei_EntityListingsExchangeAxis_exch_XNCM_us-gaap_StatementClassOfStockAxis_mdcx_WarrantsEachExercisableForOneCommonShareAtAnExercisePriceOfFourPointSixFourPerShareMember"
      id="ixv-305">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="CR20250821" id="ixv-306">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="CR20250821" id="ixv-307">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
